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1. PUBLIC HEALTH STATEMENT
 
1.1 WHAT IS 1,1,2-TRICHLOROETHANE
 
1,1,2-Trichloroethane is a colorless, sweet-smelling liquid that does
 
not burn easily and boils at a higher temperature than water. It is made
 
by two companies in the United States. It is used mostly where
 
l,l-dichloroethene (vinylidene chloride) is made. 1,1,2-Trichloroethane is
 
used as a solvent. Because information about how much is made and how it is
 
used is not available, we cannot say how much 1,1,2-trichloroethane is used,
 
where it is used, or in what products it is found. 1,1,2-Trichloroethane
 
may also be formed in landfills when 1,1,2,2-tetrachloroethane is broken
 
down. When it is released into the environment, most 1,1,2-trichloroethane
 
finally ends up in the air, but some may enter groundwater. Breakdown in
 
both the air and groundwater is slow. In the air, half the 1,1,2-trichloroethane
 
is expected to breakdown in 49 days and so it is likely to spread far from where
 
it is released before breaking down. A few studies show that 1,1,2-trichloroethane
 
below the soil surface or in groundwater does not breakdown within 16 weeks, and
 
other studies suggest that it will last for years. Some studies show that
 
breakdown of 1,1,2- trichloroethane occurs in landfills, but how fast this happens
 
is not known. For more information, see Chapters 3, 4, and 5.
 
1.2 HOW MIGHT I BE EXPOSED TO 1,1,2-TRICHLOROETHANE?
 
Low levels of 1,1,2-trichloroethane may be found in outdoor air. The
 
main source of this 1,1,2-trichloroethane is thought to be industries that
 
use it as a solvent. Because the industries that produce 1,1,2­
trichloroethane or use it to make other chemicals often recycle or burn
 
their waste, releases of 1,1,2-trichloroethane by these industries should
 
not be major sources of pollution. From surveys of industrial wastewater,
 
we learn that some of the industries that discharge 1,1,2-trichloroethane
 
are the timber products industry, plastics and synthetics industry, and
 
laundries. Limited data show that 1,1,2-trichloroethane is present in a
 
quarter to a half of city air samples. Where 1,1,2-trichloroethane is
 
found, the samples tested usually contain 10 to 50 parts of 1,1,2­
trichloroethane per trillion parts of air (ppt). Though exposure to
 
contaminated drinking water taken from groundwater sources is possible, such
 
exposure appears to be rare. A nationwide survey did not find 1,1,2­
trichloroethane in drinking water, but well water in some areas has been
 
found to contain it. Surveys found 1,1,2-trichloroethane in well water in
 
Wisconsin, New Jersey, Rhode Island, and Suffolk County, New York. The
 
largest amount in these supplies was 31 parts of 1,1,2-trichloroethane per
 
one billion parts of water (ppb). 1,1,2-Trichloroethane has not been
 
reported in food or soil. Besides the air and drinking water sources,
 
people may be exposed to 1,1,2-trichloroethane from spills and in the
 
workplace, where it may be used as a solvent. Exposure would most likely be
 
from breathing vapors of the chemical or from skin contact. When a
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is usually used in tightly closed automatic systems, so that workers are not
 
usually exposed to high levels of it. A national survey conducted in 1981­
1983 estimated that 1,036 workers were exposed to 1,1,2-trichloroethane.
 
1,1,2-Trichloroethane has been found thus far at 45 of 1177 hazardous waste
 
sites on the National Priorities List (NPL) in the United States. Landfill
 
gases from these sites may contain 1,1,2-trichloroethane. For more
 
information, please see Chapter 5.
 
1.3 HOW CAN l,l,2-TRICHLOROETHANE ENTER AND LEAVE MY BODY?
 
1,1,2-Trichloroethane can enter the body when a person breathes air
 
containing 1,1,2-trichloroethane, or when a person drinks water containing
 
this compound. It can also enter the body through the skin. After it
 
enters the body, it is carried by the blood to organs and tissues such as
 
the liver, kidney, brain, heart, spleen, and fat. Experiments in which animals
 
were given 1,1,2-trichloroethane by mouth have shown that most 1,1,2­
trichloroethane leaves the body unchanged in the breath and as other
 
substances that it was changed into in the urine in about 1 day. Very
 
little stays in the body more than 2 days. More information on how 1,1,2­
trichloroethane can enter and leave the body can be found in Chapter 2.
 
1.4 HOW CAN 1,1,2-TRICHLOROETHANE AFFECT MY HEALTH?
 
1,1,2-Trichloroethane can cause temporary stinging and burning pain on
 
the skin when humans touch it. There is no other information on the health
 
effects of 1,1,2-trichloroethane in humans. Most of what we know about the
 
health effects of this chemical comes from experiments in animals. As is
 
true with most chemicals, a large amount of 1,1,2-trichloroethane produces
 
more damage than a small amount. Short-term exposure to high levels of
 
1,1,2-trichloroethane in air or high doses given by mouth or applied to the
 
skin has caused death in animals. Long-term exposure of animals to high
 
doses given by mouth has also shortened the lifespan. These levels and
 
doses are much higher than would be found in the air, water, or food to
 
which humans might be exposed. Breathing high levels in air can affect the
 
nervous system and cause sleepiness. 1,1,2-Trichloroethane may also affect
 
the liver, kidney, and digestive tract, produce skin irritation, and affect
 
the body's ability to fight infections. Mice, but not rats, that were given
 
high doses of 1,1,2-trichloroethane by mouth for most of their life developed
 
liver cancer, but we do not know whether humans exposed to this
 
chemical would develop cancer. From the limited information available in
 
animals, it appears that 1,1,2-trichloroethane does not cause birth defects
 
or otherwise inhibit normal development. More information on the health
 
effects of 1,1,2-trichloroethane can be found in Chapter 2.
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1.6 WHAT LEVELS OF EXPOSURE HAVE RESULTED IN HARMFUL HEALTH EFFECTS?
 
Tables l-l, l-2, l-3, and l-4 show the link between exposure to 1,1,2­
trichloroethane and known health effects. Tables 1-l and l-3 show that no
 
information is available on human health effects from breathing, eating, or
 
drinking 1,1,2-trichloroethane. Minimal Risk Levels (MRLs) are included in
 
Table l-3. These MRLs were derived from animal data for both short- and
 
long-term exposure, as described in Chapter 2 and in Table 2-2. The MRLs
 
provide a basis for comparison to levels which people might encounter
 
either in the air or in food or drinking water. If a person is exposed to
 
1,1,2-trichloroethane at an amount below the MRL, it is not expected that
 
harmful (noncancer) health effects will occur. Since these levels are based
 
on information that is currently available, there is always some uncertainty
 
associated with it. Also since the method for deriving MRLs does not use
 
any information about cancer, an MRL does not imply anything about the
 
presence, absence, or level of risk of cancer. In Table l-2, death is
 
reported to occur at levels that are less than or equal to the levels that
 
cause central nervous system depression and mild liver effects. However,
 
the period of exposure that produces death is longer. More information on
 
levels of exposure linked with harmful effects can be found in Chapter 2.
 
1.7 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT HUMAN
 HEALTH? 
The Environmental Protection Agency (EPA) has allowed a limit of 0.6 
µg/L (ppb) 1,1,2-trichloroethane in waters such as lakes and streams. The 
EPA also requires industry to report discharges or spills of 100 or more 
Pounds. 
Levels of 1,1,2-trichloroethane allowed in the workplace are regulated
 
by the Occupational Safety and Health Administration (OSHA). The
 
occupational exposure limit is 10 parts of 1,1,2-trichloroethane per one
 
million parts of air (ppm) for an 8-hour workday, 40-hour workweek. More
 
information on government recommendations can be found in Chapter 7.
 
1.8 WHERE CAN I GET MORE INFORMATION?
 
If you have more questions or concerns, please contact your state
 
health or environmental department or:
 



















This chapter contains descriptions and evaluations of studies and
 
interpretation of data on the health effects associated with exposure to
 
1,1,2-trichloroethane. Its purpose is to present levels of significant
 
exposure for 1,1,2-trichloroethane based on toxicological studies,
 
epidemiological investigations, and environmental exposure data. This
 
information is presented to provide public health officials, physicians,
 
toxicologists, and other interested individuals and groups with (1) an
 
overall perspective of the toxicology of 1,1,2-trichloroethane and (2) a
 




2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE
 
To help public health professionals address the needs of persons living
 
or working near hazardous waste sites, the data in this section are
 
organized first by route of exposure -- inhalation, oral and dermal -- and
 
then by health effect -- death, systemic, immunological, neurological,
 
developmental, reproductive, genotoxic, and carcinogenic effects. These
 




Levels of significant exposure for each exposure route and duration
 
(for which data exist) are presented in tables and illustrated in figures.
 
The points in the figures showing no-observed-adverse-effect levels (NOAELS)
 
or lowest-observed-adverse-effect levels (LOAELs) reflect the actual doses
 
(levels of exposure) used in the studies. LOAELs have been classified into
 
"less serious" or "serious" effects. These distinctions are intended to
 
help the users of the document identify the levels of exposure at which
 
adverse health effects start to appear, determine whether or not the
 
intensity of the effects varies with dose and/or duration, and place into
 
perspective the possible significance of these effects to human health.
 
The significance of the exposure levels shown on the tables and graphs
 
may differ depending on the user's perspective. For example, physicians
 
concerned with the interpretation of clinical findings in exposed persons or
 
with the identification of persons with the potential to develop such
 
disease may be interested in levels of exposure associated with "serious"
 
effects. Public health officials and project managers concerned with
 
response actions at Superfund sites may want information on levels of
 
exposure associated with more subtle effects in humans or animals (LOAEL) or
 
exposure levels below which no adverse effects (NOAEL) have been observed.
 
Estimates of levels posing minimal risk to humans (minimal risk levels,
 






For certain chemicals, levels of exposure associated with carcinogenic
 
effects may be indicated in the figures. These levels reflect the actual
 
doses associated with the tumor incidences reported in the studies cited.
 
Because cancer effects could occur at lower exposure levels, the figures
 
also show estimated excess risks, ranging from a risk of one in 10,000 to
 
one in l0,000,000 (10-4 to 10-7), as developed by EPA.
 
Estimates of exposure posing minimal risk to humans (MRLs) have been
 
made, where data were believed reliable, for the most sensitive noncancer
 
endpoint for each exposure duration. MRLs include adjustments to reflect
 
human variability and, where appropriate, the uncertainty of extrapolating
 
from laboratory animal data to humans. Although methods have been
 
established to derive these levels (Barnes et al. 1987; EPA 1980c),
 




Much of the data on the health effects of 1,1,2-trichloroethane
 
following inhalation exposure were taken from a limited, unpublished study
 
conducted by Dow Chemical Company. The original study was not available for
 
review, but a brief description of the results was reported by Torkelson and
 
Rowe (1981). This study is discussed below because in some cases,
 
comparable information was not available from other reports, and in other
 
cases, the levels of exposure associated with effects were noticeably
 
different from those reported in other studies. These data indicate that
 
the health effects of 1,1,2-trichloroethane might occur over a broader range of
 
exposure levels than data from other studies would suggest. Although these results
 
are discussed below, they are not included in Table 2-1 or plotted in Figure 2-1
 
as levels of significant exposure because the details of experimental methods and
 








Mortality produced by inhalation of 1,1,2-trichloroethane has been
 
studied in animals. Three of 5 rats exposed to 2080 ppm of 1,1,2­
trichloroethane for 2 hours died within about 24 hours, but 5 rats exposed
 
to 890 ppm for 2 hours survived (Carlson 1973). Carpenter et al. (1949)
 
exposed rats to 1,1,2-trichloroethane vapor for 4 hours. They reported that
 
2-4/6 rats died within 14 days following exposure to 2000 ppm and 0-1/6 died
 
following exposure to 1000 ppm. The exact number of rats killed in each
 
treatment group was not reported. Because it was not explicitly stated that
 
no rats died following exposure to 1000 ppm, this concentration was not used
 
as a NOAEL. The LC50 of 1,1,2-trichloroethane in rats exposed for 6 hours
 
was 1654 ppm (Bonnet et al. 1980). During exposure, animals are first
 
excited and then somnolent. Most mortality occurred within 24 hours of
 








lesions in the lungs, liver, or kidneys were found at autopsy. More than
 
half of the test rats died following 7-hour exposure to 250 or 500 ppm of
 
1,1,2-trichloroethane, but no rats died following exposure to 100 ppm
 
[Unpublished data, Dow Chemical Co. (cited in Torkelson and Rowe 198l)].
 
The results of this study were not used as levels of significant exposure
 
because experimental methods and results were not described in sufficient
 
detail. In rats exposed to 1,1,2-trichloroethane for 8 hours, the LC50 was
 
999 ppm (Pozzani et al. 1959). These authors reported, in a later study,
 
that exposure to 500 ppm for 8 hours produced death in 4 out of 6 rats
 
within 14 days (Smyth et al. 1969).
 
In mice, 12,934 ppm of 1,1,2-trichloroethane was found to be the
 
minimum lethal concentration in a 2-hour exposure test (Lazarew 1929). The
 
animals lay down on their sides and lost control of their reflexes prior to
 
death. An LC50 value of 416 ppm was calculated in mice exposed for 6 hours
 
and observed for 14 days (Gradiski et al. 1978). In mice exposed to 3750
 
ppm of 1,1,2-trichloroethane, the LT50, or exposure duration that produced
 




Only one study investigated the health effects of long-term inhalation
 
exposure to 1,1,2-trichloroethane. Exposure to 15 ppm of 1,1,2­
trichloroethane for 6 months did not increase mortality in rats, guinea
 
pigs, or rabbits [Unpublished data, Dow Chemical Co. (cited in Torkelson and
 
Rowe 1981)]. Values reported by this study are not included as levels of
 
significant exposure because experimental methods and results were not
 
described in sufficient detail.
 
The highest NOAEL values and all reliable LOAEL values for death in
 
each species are recorded in Table 2-1 and plotted in Figure 2-1. The
 
concentrations of 416 ppm (Gradiski et al. 1978) and 500 ppm (Smyth et al.
 




Respiratory Effects. No studies were located regarding respiratory
 
effects in humans following inhalation exposure to 1,1,2-trichloroethane.
 
Only one study investigated the respiratory effects of 1,1,2­
trichloroethane inhalation in animals. Bonnet et al. (1980) macroscopically
 
examined the lungs of rats that survived a 6-hour exposure test from which
 
an LC50 of 1654 ppm was calculated. No lesions were found. This study was
 
not used as the basis of a NOAEL because histological examinations were not
 




Hepatic Effects. No studies were located regarding hepatic effects in
 






Several studies examined the hepatotoxicity of inhaled 1,1,2­
trichloroethane vapor in animals. In rats, inhalation of 2080 ppm of 1,1,2­
trichloroethane for 2 hours resulted in a small, but significant, increase
 
in serum glutamic-pyruvic transaminase (SGPT) levels measured 22 hours after
 
exposure ended (Carlson 1973). This treatment did not affect serum
 
glutamic-oxaloacetic transaminase (SGOT), glucose-6-phosphatase, or liver
 
weight. There were no hepatic effects after exposure to 890 ppm in this
 
study. Macroscopic examination of rats that survived exposure to 250 ppm of
 
1,1,2-trichloroethane for 4 hours, and 250-500 ppm for 7 hours, revealed
 
necrosis and tissue damage in the liver [Unpublished data, Dow Chemical Co.
 
(cited in Torkelson and Rowe 1981)]. No macroscopic lesions were found in
 
the livers of rats that survived a 6-hour exposure test from which an LC50
 
of 1654 ppm was calculated (Bonnet et al. 1980). This study was not used as
 
the basis of a NOAEL because histological examinations were not performed,
 
and gross observations alone are not sufficient to detect subtle health
 
effects. The occurrence of hepatic effects at lower concentrations in the
 
Dow Chemical study than in other studies may be due to differences in
 
duration of exposure, endpoint examined, strain of rat used, or other
 
differences in experimental protocols.
 
Mice exposed to 800 ppm of 1,1,2-trichloroethane for 3 hours had
 
decreased adenosine triphosphate (ATP), increased liver triglycerides,
 
decreased plasma triglycerides, and increased SGPT (Takahara 1986c).
 
Recovery occurred within 20 hours for all parameters except SGPT, which
 
remained elevated. The ET50 for increased SGPT levels in mice exposed to
 
3750 ppm of 1,1,2-trichloroethane (duration of exposure that produced
 
increased SGPT levels in one-half of the exposed mice) was 17.5 minutes
 




Minor fatty changes and cloudy swelling were found in the livers of
 
female rats exposed to 30 ppm of 1,1,2-trichloroethane for 16 days.
 
However, 6-month exposure to 15 ppm 1,1,2-trichloroethane did not have
 
histopathological effects on the liver in rats, guinea pigs, or rabbits
 
[Unpublished data, Dow Chemical Co. (cited in Torkelson and Rowe 1981)].
 
The highest NOAEL values and all reliable LOAEL values for hepatic
 
effects in each species are recorded in Table 2-1 and plotted in Figure 2-l.
 
Although increased SGPT is reported as a less serious effect, it is
 
suggestive of cell damage that can range from less serious to serious. The
 
study by Dow Chemical was not used as the basis of a NOAEL or LOAEL because
 
experimental details were not reported. The concentration of 800 ppm in air
 
(Takahara 1986c) is presented in Table 1-2.
 
Renal Effects. No studies were located regarding renal effects in
 
humans following inhalation exposure to 1,1,2-trichloroethane.
 
The renal effects of 1,1,2-trichloroethane have been studied in
 






hours produced kidney necrosis [Unpublished data, Dow Chemical Co. (cited in
 
Torkelson and Rowe 1981)]. Exposure to 250 or 500 ppm for 7 hours produced
 
marked kidney damage. This study was not used as the basis of a LOAEL
 
because experimental details were not reported. No macroscopic lesions were
 
found in the kidneys of rats that survived a 6-hour exposure test from which
 
an LC50 of 1654 ppm was calculated (Bonnet et al. 1980). This study was not
 
used as the basis of a NOAEL because histological examinations were not
 




In the only long-term study available, 6-month exposure to 15 ppm of
 
1,1,2-trichloroethane did not produce renal histopathological effects in
 
rats, guinea pigs, or rabbits [Unpublished data, Dow Chemical Co. (cited in
 
Torkelson and Rowe 1981)]. This study was not used as the basis of a NOAEL
 
because experimental details were not reported.
 
Other Systemic Effects. No studies were located regarding other
 
systemic effects in humans following inhalation exposure to 1,1,2­
trichloroethane.
 
One study examined the relationship between inhalation of 1,1,2­
trichloroethane and body weight in animals. Reduced body weight gain was
 
reported in rats following a 6-hour exposure test from which an LC50 of 1654
 
ppm was calculated (Bonnet et al. 1980). No level of significant exposure
 




No studies were located regarding immunological effects in humans or
 




No studies were located regarding neurological effects in humans
 
following inhalation exposure to 1,1,2-trichloroethane.
 
Studies in animals indicate that inhalation of 1,1,2-trichloroethane
 
may produce neurological effects. Exposure to 1654 ppm of 1,1,2­
trichloroethane for 6 hours produced excitation, followed by sleepiness, in
 
rats (Bonnet et al. 1980). Mice exposed to 1,1,2-trichloroethane vapor for
 
2 hours laid down on their sides at 1833 ppm, and lost control of their
 
reflexes at 2749 ppm. These concentrations are substantially lower than the
 
minimum lethal concentration of 12,934 ppm that was reported in this study,
 
which suggests that 1,1,2-trichloroethane exhibited increased central
 
nervous system depression in this study (Lazarew 1929). The ET50 for
 
anesthesia in mice exposed to 3750 ppm (duration of exposure that produced
 
anesthesia in one-half of the exposed mice) was 18 minutes (Gehring 1968).
 
This was substantially shorter than the LT50 of 600 minutes for lethality,
 






elevation in the threshold for pentylenetetrazol-induced seizures of CNS
 
function, occurred in mice after exposure to 418 ppm of 1,1,2­
trichloroethane for 4 hours (De Ceaurriz et al. 1981). This effect may
 
indicate depression of CNS function.
 
All reliable LOAEL values for neurological effects in each species are
 
recorded in Table 2-1 and plotted in Figure 2-1. The concentration of 418
 




No studies were located regarding developmental effects in humans or
 




No studies were located regarding reproductive effects in humans or
 




No studies were located regarding genotoxic effects in humans or
 




No studies were located regarding cancer in humans or animals following
 
inhalation exposure to 1,1,2-trichloroethane. Because 1,1,2-trichloroethane
 
was carcinogenic to mice by the oral route in the NCI (1978) bioassay
 
(Section 2.2.2.8), it is assumed that it is carcinogenic by inhalation, and
 
the ql* for oral exposure was adopted as the ql* for inhalation (EPA
 




(µ/m3 , which is equivalent to 8.7 x 10-2 (ppm)-1. This unit risk 
corresponds to upper bound individual lifetime cancer risks at 10-4 to 10-7 









Several reports indicate that 1,1,2-trichloroethane may be lethal to
 
animals. An LD50 of 837 mg/kg (0.58 mL/kg) was calculated for orally
 
administered, undiluted 1,1,2-trichloroethane in rats (Smyth et al. 1969).
 
Moody et al. (1981) reported no mortality among fasted rats given single
 
oral doses of 1,1,2-trichloroethane in mineral oil at 1080 mg/kg, but this
 











after administration were recorded, and only 3 rats were tested. In mice,
 
the oral LD50 of 1,1,2-trichloroethane administered by gavage in water was
 
reported to be 378 mg/kg for males and 491 mg/kg for females (White et al.
 
1985). The lower value of 378 mg/kg, which was obtained in the males, was
 
used in Table 2-2 and Figure 2-2. Necropsy of mice that died in this study
 
revealed hemorrhagic areas in the lungs and pale coloration of the liver,
 
which may also have been caused by hemorrhage. These effects may have
 
contributed to the death of these animals. The only dog given 1,1,2­
trichloroethane (vehicle not specified) at 722 mg/kg died, but all 5 that
 




Lethality was investigated in two short-term repeated-dose studies.
 
Oral doses of 1,1,2-trichloroethane given by gavage in water at 300 mg/kg,
 
repeated daily for 7 days, resulted in the death of all 7 mice tested
 
(Kallman et al. 1983). Doses up to 100 mg/kg/day did not produce death in
 
this study. Oral administration by gavage of 38 mg/kg/day in 10% Emulphor
 
for 14 days did not produce mortality in mice (White et al. 1985).
 
One long-term study investigated the effect of 1,1,2-trichloroethane on
 
animal survival. Mice were given daily oral doses of 1,1,2-trichloroethane
 
at 195 or 390 mg/kg in corn oil for 78 weeks (NCI 1978). Although male
 
survival was not affected, female survival was reduced in a dose-dependent
 
manner. A large number of the deaths in the female low dose group occurred
 
early in the experiment; these were not tumor-related and did not appear to
 
have a common cause. In rats, survival was not affected by oral
 
administration of doses of 1,1,2-trichloroethane at either 46 or 92
 
mg/kg/day for 78 weeks (NCI 1978). However, rat vehicle controls had
 
unusually high mortality in this study.
 
The highest NOAEL values and all reliable LOAEL values for death in
 
each species and duration category are recorded in Table 2-2 and plotted in
 
Figure 2-2. No short-term studies of 1,1,2-trichloroethane administered in
 
drinking water were located; therefore the dose level of 837 mg/kg/day,
 
which was administered by gavage undiluted (Smyth et al. 1969), and the dose
 
level of 378 mg/kg/day, which was administered by gavage in water (White et
 
al. 1985), were converted to equivalent concentrations, respectively, of
 
5980 and 1990 ppm in water for presentation in Table l-4. No long-term
 
studies of 1,1,2-trichloroethane administered in food were located;
 
therefore the dose level of 195 mg/kg/day, which was administered by gavage
 
in corn oil (NCI 1978), was converted to an equivalent concentration of 1500
 




Respiratory Effects. No studies were located regarding respiratory
 






Respiratory effects have been studied in animals. Hemorrhagic areas
 
were found in the lungs of mice that died following gavage administration of
 
1,1,2-trichloroethane in water at 200 to 600 mg/kg (White et al. 1985).
 
This study was not used as the basis of a LOAEL because the effect was
 
reported only in mice that died as a result of exposure. Daily
 
administration of 1,1,2-trichloroethane by gavage in 10% Emulphor at
 
38 mg/kg for 14 days did not affect lung weight in the mouse (White et al.
 
1985). Consumption of 305 mg/kg/day by males and 384 mg/kg/day by females
 
in the drinking water for 90 days was also without effect on mouse lung
 
weight (White et al. 1985). These dose levels were not used as NOAEL values
 
because lung weight alone may not be an adequate endpoint to assess possible
 
tissue damage. However, organ weight changes, when they occur in
 
conjunction with other subtle effects, may indicate tissue damage.
 
Histopathological examination of respiratory organs and tissues using light
 
microscopy found no increase in the occurrence of non-neoplastic lesions
 
following 78 weeks of oral 1,1,2-trichloroethane administration in corn oil
 
at doses of 46 or 92 mg/kg/day in rats and 195 or 390 mg/kg/day in mice (NCI
 
1978). NOAEL values for respiratory effects derived from this study are
 
recorded in Table 2-2 and plotted in Figure 2-2.
 
Cardiovascular Effects. No studies were located regarding
 
cardiovascular effects in humans following oral exposure to 1,1,2­
trichloroethane.
 
One study of cardiovascular effects in animals was located.
 
Histopathological examination of cardiovascular tissues using light
 
microscopy found no increase in the occurrence of non-neoplastic lesions
 
following 78 weeks of oral 1,1,2-trichloroethane administration in corn oil
 
at doses of 46 or 92 mg/kg/day in rats and 195 or 390 mg/kg/day in mice (NCI
 
1978). NOAEL values for cardiovascular effects in each species are recorded
 
in Table 2-2 and plotted in Figure 2-2.
 
Gastrointestinal Effects. No studies were located regarding
 
gastrointestinal effects in humans following oral exposure to 1,1,2­
trichloroethane.
 
There is some evidence for adverse gastrointestinal effects in animals.
 
Mice that died following administration by gavage in water of single oral
 
doses of 1,1,2-trichloroethane above 200 mg/kg displayed a dose-related
 
increase in the incidence of gastric irritation until all animals were
 
affected at 500 mg/kg (White et al. 1985). This study was not used as the
 
basis of a LOAEL because the effect was reported only in mice that died as a
 
result of exposure. Mild inflammation and congestion of the
 
gastrointestinal tract, as well as nausea, were noted in a dog given oral
 
administration (vehicle not specified) of 144 mg/kg (Wright and Schaffer
 
1932). Severe irritation and hemorrhage were found in 2 of the 3 dogs given
 
doses of 433 or 722 mg/kg. Histopathological examination of
 
gastrointestinal organs and tissues by light microscopy revealed no increase
 






1,1,2-trichloroethane administration by gavage in corn oil at doses of 46 or
 
92 mg/kg/day in rats and 195 or 390 mg/kg/day in mice (NCI 1978). The
 
highest NOAEL values and all reliable LOAEL values for gastrointestinal
 
effects in each species and duration category are recorded in Table 2-2 and
 
plotted in Figure 2-2.
 
Hematological Effects. No studies were located regarding hematological
 
effects in humans following oral exposure to 1,1,2-trichloroethane.
 
In animals, hematological effects were the subject of several studies.
 
No hematological effects were found after daily administration to mice of
 
1,1,2-trichloroethane by gavage in Emulphor at 38 mg/kg for 14 days (White
 
et al. 1985). No hematological effects were found in male mice exposed to
 
≤305 mg/kg/day in the drinking water for 90 days, but changes in 
hematological parameters were recorded in females that received doses as low 
as 3.9 mg/kg/day (White et al. 1985). These included mild decreases in 
hematocrit and hemoglobin at 384 mg/kg/day, increases in platelets and 
fibrinogen that were found in all groups, but were not dose-related, and 
leukocytes that were elevated, compared to controls, in the high-dose group, 
but which were only slightly higher than the historical control value in 
this laboratory. There was also a decrease in prothrombin time that 
appeared to be dose-related and became significant at 44 mg/kg/day. These 
changes were not clearly adverse to the mice, so only a NOAEL was derived 
from this study. Histopathological examination of spleen and bone marrow 
using light microscopy found no increase in the occurrence of non-neoplastic 
lesions following 78 weeks of oral 1,1,2-trichloroethane administration in 
corn oil at doses of 46 or 92 mg/kg/day in rats and 195 or 390 mg/kg/day in 
mice (NCI 1978). The NOAEL values for hematological effects in each species 
and duration category are recorded in Table 2-2 and plotted in Figure 2-2. 
Musculoskeletal Effects. No studies were located regarding
 
musculoskeletal effects in humans following oral exposure to 1,1,2­
trichloroethane.
 
Only one study investigated musculoskeletal effects in animals.
 
Histopathological examination of musculoskeletal tissues by light
 
microscopy revealed no increase in the occurrence of non-neoplastic lesions
 
following 78 weeks of oral 1,1,2-trichloroethane administration in corn oil
 
at doses of 46 or 92 mg/kg/day in rats and 195 or 390 mg/kg/day in mice (NCI
 
1978). NOAEL values for musculoskeletal effects in each species are
 
recorded in Table 2-2 and plotted in Figure 2-2.
 
Hepatic Effects. No studies were located regarding hepatic effects in
 
humans following oral exposure to 1,1,2-trichloroethane.
 
Necropsy of mice that died following single oral doses of 1,1,2­
trichloroethane by gavage in water at 200 to 600 mg/kg revealed pale
 
coloration of the liver (White et al. 1985). This study was not used as the
 






result of exposure. Dogs given 144 mg/kg or more had congestion, fatty
 
degeneration, edema, and the onset of necrosis in the liver (Wright and
 
Schaffer 1932). Massive liver necrosis occurred in 1 of the 3 dogs given
 
433 mg/kg or above. Tyson et al. (1983) found significant increases in SGOT
 
and SGPT following oral administration of 1,1,2-trichloroethane in corn oil
 
to rats. The ED50 for this effect was 60 mg/kg. Decreases in cytochrome P­
450, ALA-dehydratase, and glutathione levels occurred after administration
 
of 1080 mg/kg by gavage in mineral oil in rats (Moody et al. 1981, Moody and
 
Smuckler 1986). Increased relative liver weight and alterations in fatty
 
acid content of liver microsomes (increased oleic acid and decreased
 
arachidonic acid content) were also seen in this study, which was limited by
 
small sample size (Moody et al. 1981). Glucose-6-phosphate dehydrogenase
 
levels increased 195%, and NADH2-cytochrome c reductase levels decreased
 
33%, in rats administered 1,1,2-trichloroethane orally in liquid paraffin at
 
180 mg/kg/day for 7 days (Platt and Cockrill 1969). Liver weight,
 
microsomal and cell-sap protein concentrations, and levels of NADPH2­
cytochrome c reductase, aminopyrine demethylase, glucose-6-phosphatase,
 
lactate dehydrogenase, glutamate dehydrogenase, and 6-phosphogluconate
 
dehydrogenase were not significantly changed in this study. SGPT levels
 
were not affected by 14-day administration of 1,1,2-trichloroethane by
 
gavage in an aqueous Emulphor emulsion at 38 mg/kg/day in mice (White et al.
 
1985). In male mice exposed to 1,1,2-trichloroethane for 90 days in the
 
drinking water, liver glutathione decreased 16% following exposure to 46
 
mg/kg/day and 28% following exposure to 305 mg/kg/day; serum transaminase
 
levels were not significantly increased at either dose (White et al. 1985).
 
In the same study, female mice that received 384 mg/kg/day had a 13%
 
increase in liver glutathione and significantly elevated SGPT levels. SGOT
 
levels were increased in females exposed to 3.9 mg/kg/day and above, but
 
this was not considered to be a compound-related effect because no dosedependency
 
was established. The NOAEL for liver effects in this study was taken to be 4.4
 
mg/kg/day. Based on this value, which was rounded off to 4mg/kg/day, an
 
intermediate oral MRL of 0.04 mg/kg/day was calculated, as
 
described in the footnote in Table 2-2. This MRL has been converted to an
 
equivalent concentration in water (1.4 ppm) for presentation in Table 1-3.
 
No increase in the occurrence of non-neoplastic lesions in the liver was
 
found by light microscopic histopathological examination following 78 weeks
 
of oral 1,1,2-trichloroethane administration by gavage in corn oil at doses
 
of 92 mg/kg/day in rats and 390 mg/kg/day in mice (NCI 1978).
 
The highest NOAEL values and all reliable LOAEL values for hepatic
 
effects in each species and duration category are recorded in Table 2-2 and
 
plotted in Figure 2-2. No short-term studies of 1,1,2-trichloroethane
 
administered in food were located; therefore, the dose level of 60
 
mg/kg/day, which was administered by gavage in corn oil (Tyson et al. 1983),
 
was converted to an equivalent concentration of 1200 ppm in food for
 
presentation in Table 1-4. The dose of 46 mg/kg/day was calculated from an
 
administered concentration of 200 ppm in water (White et al. 1985). This
 






Renal Effects. No studies were located regarding renal effects in
 
humans following oral exposure to 1,1,2-trichloroethane.
 
There are some reports of renal toxicity in animals, although most
 
studies reported negative results. Cloudy swelling and congestion of the
 
kidney were found by histopathological examination in dogs given 1,1,2­
trichloroethane orally (vehicle not specified) at doses of 144 mg/kg or
 
above (Wright and Schaffer 1932). There was a significant, low-level
 
depression of in vitro organic ion uptake in renal cortical slices taken
 
from rats given single oral doses of 1,1,2-trichloroethane in corn oil at 72
 
to 505 mg/kg (Watrous and Plaa 1972a). There was no clear dose-response
 
relationship in this study, however. In mice administered 1,1,2­
trichloroethane at up to 2886 mg/kg, the results were more inconsistent,
 
with significant increases and decreases reported at various doses in
 
different trials (Watrous and Plaa 1972a). Consequently, this study was not
 
used as the source of a level of significant exposure in either species.
 
There were no significant changes in kidney weight or blood urea nitrogen,
 
an indicator of kidney function, in mice given 1,1,2-trichloroethane by
 
gavage in 10% Emulphor for 14 days at a dose of 38 mg/kg/day or in the
 
drinking water for 90 days at a dose of 305 mg/kg/day in males and 384
 
mg/kg/day in females (White et al. 1985). No increase in the occurrence of
 
non-neoplastic lesions was found in the kidney by light microscopic
 
histopathological examination following 78 weeks of oral 1,1,2-trichloroethane
 
administration in corn oil at doses of 92 mg/kg/day in rats and 390 mg/kg/day in
 
mice (NCI 1978). The highest NOAEL values and all reliable LOAEL values for renal
 
effects in each species and duration category are recorded in Table 2-2 and
 
plotted in Figure 2-2.
 
Dermal/Ocular Effects. No studies were located regarding dermal or
 
ocular effects in humans following oral exposure to 1,1,2-trichloroethane.
 
Only one study evaluated dermal or ocular effects in animals.
 
Histopathological examination of the skin and eye using light microscopy
 
found no increase in the occurrence of non-neoplastic lesions following 78
 
weeks of oral 1,1,2-trichloroethane administration in corn oil at doses of
 
46 or 92 mg/kg/day in rats and 195 or 390 mg/kg/day in mice (NCI 1978).
 
NOAEL values for dermal/ocular effects in each species are recorded in Table
 
2-2 and plotted in Figure 2-2.
 
Other Systemic Effects. No studies were located regarding other
 
systemic effects in humans following oral exposure to 1,1,2-trichloroethane.
 
The effect of 1,1,2-trichloroethane on body weight was investigated in
 
several reports. Moody et al. (1981) reported reduced body weight gain in
 
rats orally exposed to 1,1,2-trichloroethane in mineral oil at 1080 mg/kg,
 
but a LOAEL was not derived because no data were presented. Rats given 180
 
mg/kg/day in liquid paraffin for 7 days grew only 8% over the course of the
 
experiment, whereas control rats grew 34% (Platt and Cockrill 1969). Growth
 






oil for 7 weeks (Story et al. 1986). In mice, body weight gain was not
 
significantly affected by gavage administration of 1,1,2-trichloroethane in
 
10% Emulphor at 38 mg/kg/day for 14 days (White et al. 1985). Kallman and
 
Kaempf (1984) reported that body growth in male mice was unchanged by go-day
 
exposure to 46 mg/kg/day in the drinking water. Exposure to 1,1,2­
trichloroethane in the drinking water for 90 days produced a concentration-

dependent reduction in weight gain in male mice that was significant at 305
 
mg/kg/day (White et al. 1985). Weight gain in female mice was not affected in this
 
study. When administered by gavage in corn oil, doses of 92 mg/kg/day in rats and
 
390 mg/kg/day in mice for 78 weeks (NCI 1978) did not inhibit body growth. The
 
highest NOAEL and all reliable LOAEL values for reduced growth in each species and
 
duration category are recorded in Table 2-2 and plotted in Figure 2-2. Some of the
 






No studies were located regarding immunological effects in humans
 
following oral exposure to 1,1,2-trichloroethane.
 
Immunological effects in mice were studied by Sanders and co-workers
 
(Sanders et al. 1985, White et al. 1985). Oral administration of 1,1,2­
trichloroethane to male mice at gavage doses in 10% Emulphor up to 38 mg/kg
 
once a day for 14 days had no effect on humoral or cell-mediated immune
 
response to sheep red blood cells (Sanders et al. 1985). Humoral immune
 
response was measured by the number of IgM antibody forming cells produced
 
against sheep red blood cells in the spleen. Spleen and thymus weight were
 
not affected by treatment (White et al. 1985). A NOAEL of 38 mg/kg/day for
 




In a longer-term study, mice were exposed to 1,1,2-trichloroethane in
 
the drinking water for 90 days (Sanders et al. 1985, White et al. 1985).
 
Males received doses of 4.4, 46, and 305 mg/kg/day and females received
 
doses of 3.9, 44, and 384 mg/kg/day. Humoral immune response was measured
 
by the number of IgM antibody forming cells produced against sheep red blood
 
cells in the spleen, hemagglutination titers, and spleen lymphocyte response
 
to lipopolysaccharide (Sanders et al. 1985). The number of antibody forming
 
cells in the spleen was not consistently affected by treatment. A
 
significant increase was obtained in females that received 384 mg/kg/day,
 
but only on day 4 following immunization and only when counted on a 106 cell
 
basis. Significant increases were also found by some measurements in low-dose
 
males, but high-dose males were not affected. Hemaglutination titers
 








Cell-mediated immune response to sheep red blood cells was not affected
 
in any group tested by Sanders et al. (1985). Both delayed-type hypersensitivity
 
and popliteal lymph node proliferation responses were examined. Other immune
 
responses were also evaluated. Peritoneal macrophages from males exposed to 305
 
mg/kg/day had a significantly depressed ability to phagocytize sheep red blood
 
cells. This effect was not found in females. The functional activity of the fixed
 
macrophages of the reticuloendothelial system was altered in females exposed to
 
384 mg/kg/day, which had a 17% increase in vascular clearance of sheep red blood
 
cells, but not males. Spleen weight was unchanged in most groups, but was
 
increased in females exposed to 384 mg/kg/day (White et al. 1985). Thymus weight
 
was not affected in any group.
 
On the basis of this study, 44 mg/kg was chosen as the LOAEL and 4.4
 
mg/kg/day as the NOAEL for immunological effects in oral studies of
 
intermediate duration. The dose of 44 mg/kg/day was calculated from an
 
administered concentration of 200 ppm in water by Sanders et al. (1985).
 
This concentration is presented in Table l-4.
 
No increase in the occurrence of non-neoplastic lesions was found in
 
organs and tissues of the immune system following 78 weeks of oral 1,1,2­
trichloroethane administration in corn oil at doses of 46 or 92 mg/kg/day in
 
rats and 195 or 390 mg/kg/day in mice (NCI 1978). This study involved
 
histopathological examination of the spleen, thymus, and lymph nodes using
 
light microscopy, but because specific tests for immunotoxicity were not
 




No studies were located regarding neurological effects in humans
 
following oral exposure to 1,1,2-trichloroethane.
 
1,1,2-Trichloroethane has neurological effects in acutely exposed
 
animals. All mice given single oral doses of 1,1,2-trichloroethane at 450
 
mg/kg or more in water were sedated within 1 hour of administration (White
 
et al. 1985). The ED50 for motor impairment (dose that produced motor
 
impairment in one half of the test animals) in mice was 128 mg/kg
 
administered by gavage in water (Borzelleca 1983). The peak effect occurred
 
within 5 minutes of exposure. In dogs, doses of 1,1,2-trichloroethane at
 
289 to 722 mg/kg (vehicle not specified) produced drowsiness,
 




Kallman et al. (1983) reported that 1,1,2-trichloroethane administered
 
by gavage in water produced a significant dose-related taste aversion to
 
saccharin in the drinking water. The NOAEL for this effect was 30 mg/kg and
 






display a taste aversion to 1,1,2-trichloroethane itself when 46 mg/kg/day
 
was added to the drinking water for 4 days (Kallman and Kaempf 1984).
 
Longer-term studies did not report neurological effects following oral
 
administration of 1,1,2-trichloroethane. Administration of 38 mg/kg/day in
 
10% Emulphor for 14 days did not affect brain weight in mice (White et al.
 
1985). Mouse brain weight was also unaffected by exposure to 305-384
 
mg/kg/day in the drinking water for 90 days (White et al. 1985). NOAEL
 
values were not derived from these studies because brain weight alone is
 
not an adequate endpoint to assess neurotoxicity. No effect on the occur­
rence of non-neoplastic lesions in nervous system organs and tissues
 
was found by histopathological examination using light microscopy following
 
78 weeks of oral 1,1,2-trichloroethane administration in corn oil at doses
 
of 46 or 92 mg/kg/day in rats and 195 or 390 mg/kg/day in mice (NCI 1978).
 
NOAEL values were not derived from this study because tests of nervous
 
system function were not included, and histopathology alone may not be an
 
adequate endpoint to assess neurotoxicity.
 
The highest NOAEL values and all reliable LOAEL values for neurological
 
effects in each species are recorded in Table 2-2 and plotted in Figure 2-2.
 
Effects were not reported by short-term studies of 1,1,2-trichloroethane in
 
drinking water; therefore, the dose levels of 100 mg/kg/day, resulting in
 
taste aversion (Kallman et al. 1983), and 128 mg/kg/day, resulting in motor
 
impairment (Borzelleca 1983), which were administered by gavage in water,
 
were converted to equivalent concentrations of 525 and 670 ppm, respectively,
 
for presentation in Table 1-4. Based on the NOAEL of 30mg/kg/day, an acute oral
 
MRL of 0.3 mg/kg/day was calculated as described in the footnote in Table 2-2.
 
This MRL has been converted to an equivalent NOAEL of 30 concentration in water
 




No studies were located regarding developmental effects in humans
 
following oral exposure to 1,1,2-trichloroethane.
 
One study of the developmental effects of 1,1,2-trichloroethane in
 
animals was found. Pregnant female mice were orally administered 1,1,2­
trichloroethane in corn oil at 350 mg/kg/day on days 8 through 12 of
 
gestation (Seidenberg et al. 1986). The percent survival of neonates from
 
day 1 through day 3 was not affected by treatment, and neither was average
 
neonatal weight measured on days 1 and 3 post partum. A NOAEL for
 
developmental effects was not derived from this study because more explicit
 






No studies were located regarding reproductive effects in humans
 






Studies of orally administered 1,1,2-trichloroethane did not report
 
significant reproductive effects in animals. Seidenberg et al. (1986) found
 
no effect on number of litters resorbed or average number of neonates per
 
litter in mice following oral administration of 350 mg/kg/day in corn oil on
 
days 8 through 12 of gestation. This was a minimally toxic dose expected to
 
produce significant maternal weight reduction and up to 10% maternal
 
mortality. Maternal body weight was not affected in this study, but some
 
maternal mortality did occur. A NOAEL of 350 mg/kg/day derived from this
 
study is recorded in Table 2-2 and plotted in Figure 2-2. Testis weight in
 
mice was not affected when 1,1,2-trichloroethane was administered by gavage
 
in 10% Emulphor for 14 days at a dose of 38 mg/kg/day (White et al. 1985).
 
Exposure to 46 mg/kg/day or above in the drinking water for 90 days produced
 
a significant increase in relative, but not absolute, testis weight in mice
 
(White et al. 1985). NOAEL and LOAEL values were not derived from these
 
studies, however, because testes weight alone may not be an adequate
 
endpoint to assess reproductive toxicity. Also, changes in testis weight
 
are not necessarily associated with reproductive dysfunction. No effect on
 
the occurrence of non-neoplastic lesions in structures of the reproductive
 
system was found by histopathological examination using light microscopy
 
following 78 weeks of oral 1,1,2-trichloroethane administration in corn oil
 
at doses of 46 or 92 mg/kg/day in rats and 195 or 390 mg/kg/day in mice (NCI
 
1978). NOAEL values were not derived from this study because tests of
 
reproductive function were not included and histopathology alone may not be
 




No studies were located regarding genotoxic effects in humans or
 








One study of cancer in animals orally exposed to 1,1,2-trichloroethane
 
was located. There was no significant increase in the occurrence of
 
neoplasms in Osbourne-Mendel rats of either sex following 78 weeks of oral
 
1,1,2-trichloroethane administration in corn oil at doses of 46 or 92
 
mg/kg/day (NCI 1978). In B6C3Fl mice, there was a highly significant dose-

related increase in the incidence of hepatocellular carcinomas in both males and
 
females following 78 weeks of oral administration in corn oil at doses of 195 or
 
390 mg/kg/day (NCI 1978). These carcinomas were found in 10
 
percent of untreated control males, 12 percent of vehicle control males, 37
 
percent of low-dose males, and 76 percent of high-dose males; they were
 
found in 10 percent of untreated control females, 0% of vehicle control
 
females, 33% of low-dose females, and 89% of high-dose females. In
 






pheochromocytomas in mice of both sexes at 390 mg/kg/day. These lesions,
 
not found in the control or low-dose groups, had an incidence of 17 percent
 
in high-dose males and 28 percent in high-dose females. The value of this
 
study is limited by its relatively short duration of 78 weeks and its
 
conduct before the implementation of Good Laboratory Practices (GLP). A
 
Cancer Effect Level (CEL) of 195 mg/kg/day is recorded in Table 2-2 and
 
plotted in Figure 2-2. A ql* of 5.73 x 10-2 (mg/kg/day)-1 was calculated
 
for 1,1,2-trichloroethane based on the incidence of hepatocellular carcinoma
 
in male mice (EPA 1980, 1988a). This q1* was used to calculate upper bound
 
individual lifetime cancer risks at 10-4 to 10-7 risk levels of 1.8 x 10-3
 










Dermally applied 1,1,2-trichloroethane has been reported to cause death
 
in animals. A single dermal application of 116 mg/cm2 (0.25 mL applied to a
 
3.1 cm2 area of the back) was allowed to remain on the skin of guinea pigs
 
until it disappeared (5 to 7 days). This treatment resulted in the death of
 
25% of the guinea pigs tested within 28 days (Wahlberg 1976). Doses of 233
 
and 931 mg/cm2 killed all tested animals within 3 days in this study. A
 
dose of 116 mg/cm2 is, therefore, indicated as a LOAEL in Table 2-3 and
 
Figure 2-3 for acute dermal exposure to 1,1,2-trichloroethane in guinea
 
pigs. A dermal LD50 of 3.73 mL/kg (see Table 2-3) was reported for rabbits
 
(Smyth et al. 1969). This value could not be plotted in Figure 2-3 because
 




Hepatic Effects. No studies were located regarding hepatic effects in
 
humans following dermal exposure to 1,1,2-trichloroethane.
 
One study investigated the hepatotoxicity of dermally applied 1,1,2­
trichloroethane in animals. Guinea pig liver glycogen content was reduced
 
within 2 hours following dermal application of 1 mL of 1,1,2-trichloroethane
 
to a 3.1 cm2 area of the back (465 mg/cm2) (Kronevi et al. 1977). Hydropic
 
changes in the liver were also found. These effects may not have been
 
compound-related, however, since they were found in animals killed under
 
anesthesia produced by pentobarbital, but not unanesthetized animals.
 
Untreated controls were not used in this study. The authors suggest that
 
these liver effects may be due to an interaction between 1,1,2­










Renal Effects. No studies were located regarding renal effects in
 
humans following dermal exposure to 1,1,2-trichloroethane.
 
The renal effects of dermally applied 1,1,2-trichloroethane in animals
 
were examined in one study. No histopathological changes were found in the
 
kidneys of guinea pigs 2, 6, or 12 hours after dermal application of 1,1,2­
trichloroethane at 465 mg/cm2 (Kronevi et al.mg/cm21977). The NOAEL of 465 is
 
presented in Table 2-3 and plotted in Figure 2-3.
 
Dermal/Ocular Effects. The effect of 1,1,2-trichloroethane on the
 
human skin was the subject of several reports. A human subject given 5
 
minute dermal exposure to 1,1,2-trichloroethane under occlusion at 698
 
mg/cm2 (1.5 mL on 3.1 cm2 of the forearm) reported stinging and burning
 
sensations and displayed transient whitening of the skin (Wahlberg 1984a).
 
A small, immediate increase in blood flow was measured by laser Doppler
 
flowmetry, but no visible erythema was present. The acute human LOAEL was
 
taken to be 698 mg/cm2 on the basis of this report (see Table 2-3 and Figure
 
2-3). In general, use of a cover disk markedly enhances the percutaneous
 
absorption and dermal irritant properties of volatile organic chemicals,
 
which would usually evaporate from the skin's surface. In an open test on
 
the same subject, in which 0.1 mL of 1,1,2-trichloroethane was applied to
 
the skin without a cover disc, there was no effect on blood flow and no
 
visible erythema was found (Wahlberg 1984a). A volunteer given daily open
 
application of 0.1 mL of 1,1,2-trichloroethane for 15 days did not have any
 
visible skin reactions, nor was there any increase in skin-fold thickness,
 
which was measured using calipers (Wahlberg 1984b). These doses are
 
presented in Table 2-3, but could not be converted to per-area units in the
 
open tests because the area of application was not limited to the 3.1 cm2 of
 
the cover disc, so they are not plotted in Figure 2-3.
 
The dermal effects of 1,1,2-trichloroethane have also been studied in
 
animals. Dermal application of 1,1,2-trichloroethane at 465 mg/cm2 produced
 
pyknotic nuclei in epidermal cells within 15 minutes in guinea pigs (Kronevi
 
et al. 1977). As the duration of exposure increased, damage progressed to
 
vesicle formation and separation of skin layers (Kronevi et al. 1977). A
 
LOAEL of 465 mg/cm2 for acute dermal effects in guinea pigs is reported in
 
Table 2-3 and plotted in Figure 2-3. Rabbits given a single application of
 
0.01 mL of 1,1,2-trichloroethane had no effects other than slight capillary
 
congestion (Smyth et al. 1969) (see Table 2-3). This study was not plotted
 
on Figure 2-3 because the dose was not reported in per-area units. Duprat
 
et al. (1976) compared the dermal irritancy of chlorinated aliphatic
 
solvents in rabbits and determined that 1,1,2-trichloroethane was a severe
 
skin irritant compared to other compounds in this group, producing serious
 
erythema, serious edema, and necrosis. The results of this study were not
 
used for a LOAEL because no dose was reported. In a repeated-dose study,
 
daily open application of 0.1 mL for 10 days increased skin-fold thickness
 
170% in guinea pigs and 218% in rabbits (Wahlberg 1984b). All animals in
 






were also seen. The LOAEL is presented in Table 2-3 but not in Figure 2-3
 
because the dose was not reported in per-area units.
 
1,1,2-Trichloroethane applied directly to the eye did not produce
 
significant cornea1 necrosis in rabbits (Smyth et al. 1969). It was
 
classified as a slight eye irritant by Duprat et al. (1976), who found
 
moderate catarrhal conjunctivitis and epithelial abrasion following
 
application in rabbits. Neither study reported the dose of 1,1,2­






No studies were located regarding immunological effects in humans or
 




No studies were located regarding neurological effects in humans
 
following dermal exposure to 1,1,2-trichloroethane.
 
One study of neurological effects in animals was located. No
 
histopathological changes were found in the brains of guinea pigs 2, 6, or
 
12 hours after dermal application of 1,1,2-trichloroethane at 465 mg/cm2
 
(Kronevi et al. 1977). A NOAEL was not derived from this study because
 
tests of nervous system function were not included, and histopathology alone
 




No studies were located regarding developmental effects in humans or
 




No studies were located regarding reproductive effects in humans or
 




No studies were located regarding genotoxic effects in humans or
 




No studies were located regarding cancer in humans or animals following
 






2.3 RELEVANCE TO PUBLIC HEALTH
 
Other than studies on dermal irritation, no studies were located
 
regarding health effects in humans following inhalation, oral, or dermal
 
exposure to 1,1,2-trichloroethane; therefore, all implications for public
 
health are derived from animal studies.
 
Lethality. 1,1,2-Trichloroethane produced mortality in animals by all
 
routes of exposure tested, including inhalation, oral, dermal,
 
intraperitoneal injection, and subcutaneous injection. Death was produced
 
in rats, mice, guinea pigs, rabbits, and dogs, although not every species
 
was tested by every route of exposure.
 
There is some evidence that mice were more susceptible than rats to
 
1,1,2-trichloroethane-induced mortality following acute inhalation, oral and
 
intraperitoneal exposure. Inhalation LC50 values for rats and mice were
 
1654 and 416 ppm, respectively, in two studies done in the same laboratory
 
(Bonnet et al. 1980, Gradiski et al. 1978). Oral LD50 values for rats and
 
mice were 837 mg/kg (administered by gavage undiluted) and 378 mg/kg
 
(administered by gavage as an aqueous emulsion), respectively, but only
 
studies by different groups of investigators were available for comparison
 
(Smyth et al. 1969, White et al. 1985). Rat and mouse intraperitoneal LD50
 
values were 938 and 505 mg/kg, respectively, in two tests performed by the
 
same investigators (Klaassen and Plaa 1966, 1969). In each of these cases,
 
mice proved to be more susceptible to death produced by 1,1,2­
trichloroethane than rats. However, the maximum tolerated oral dose was
 
higher in mice (300 mg/kg/day) than rats (70 mg/kg/day) in a 6-week study in
 
which 1,1,2-trichloroethane was administered by gavage in corn oil (NCI
 
1978). Differences in duration of exposure, vehicle, and strain of animal
 
used may account for the discrepancy between this study and the others.
 
Metabolism of 1,1,2-trichloroethane occurs at a faster rate in mice than in
 
rats (Mitoma et al. 1985), and it is possible that greater amounts of
 
reactive metabolites in mice are responsible for the species difference in
 
susceptibility to this chemical.
 
In addition, there may be sex differences in sensitivity to 1,1,2­
trichloroethane. This compound was more toxic to male mice (LD50 = 378
 
mg/kg) than female mice (LD50 = 491 mg/kg) following acute oral
 
administration (White et al. 1985). However, survival was reduced in female
 
mice given chronic oral administration of 1,1,2-trichloroethane, but not in
 
males (NCI 1978). No sex difference was noted in LD50 values determined
 




Levels of 1,1,2-trichloroethane that produce mortality have been
 
identified in a number of species, and by several routes of exposure.
 
Exposure to high levels of 1,1,2-trichloroethane may also be fatal to
 
humans. Species and sex variation in susceptibility make it difficult to
 






Hepatic Effects. 1,1,2-Trichloroethane had adverse effects on the
 
livers of rats, mice, guinea pigs, and dogs when administered orally or by
 
inhalation. These effects included necrosis, elevated SGPT and SGOT levels,
 
and reduced liver glycogen content (Gehring 1968, Tyson et al. 1983, White
 
et al. 1985, Wright and Schaffer 1932). Intraperitoneal studies in these
 
same four species revealed similar hepatic effects, including centrilobular
 
necrosis, elevated SGPT levels, increased serum ornithine carbamyl
 
transferase activity, and fatty changes (Klaassen and Plaa 1966, Klaassen
 
and Plaa 1967a, Traiger and Plaa 1974, Divincenzo and Krasavage 1974, Harms
 
et al. 1976, MacDonald et al. 1982). 1,1,2-Trichloroethane was also toxic
 
to isolated rat hepatocytes in vitro (Tyson et al. 1980, Jernigan et al.
 
1983, Chang et al. 1985). A sex difference in susceptibility was noted by
 
White et al. (1985), who reported that female mice exposed to 384 mg/kg/day
 
in the drinking water for 90 days had significantly elevated SGPT levels,
 
but males exposed to 304 mg/kg/day did not. These investigators also found
 
that liver glutathione decreased in males and increased in females.
 
Although there is no information available to suggest that 1,1,2­
trichloroethane is a liver toxin in humans, it is considered a potential
 
human hepatotoxin because experiments in animals indicate hepatotoxic
 
potential in all species tested.
 
One mechanism that has been proposed to explain the hepatotoxicity of
 
1,1,2-trichloroethane is the generation of free radical intermediates from
 
reactive metabolites of 1,1,2-trichloroethane (acyl chlorides). Free
 
radicals may stimulate lipid peroxidation which, in turn, may induce liver
 
injury (Albano et al. 1985). However, Klaassen and Plaa (1969) found no
 
evidence of lipid peroxidation in rats given near-lethal doses of 1,1,2­
trichloroethane by intraperitoneal injection. Takano and Miyazaki (1982)
 
determined that 1,1,2-trichloroethane inhibits intracellular respiration by
 
blocking the electron transport system from reduced nicotinamide adenine
 
dinucleotide (NADH) to coenzyme Q (CoQ), which would deprive the cell of
 
energy required to phosphorylate adenosine diphosphate (ADP) and thereby
 
lead to depletion of energy stores.
 
Renal Effects. There was only one reliable report of kidney damage
 
following oral exposure to 1,1,2trichloroethane. Wright and Schaffer
 
(1932) found cloudy swelling and congestion in the kidneys of treated dogs.
 
No kidney pathology was found after dermal application in guinea pigs
 
(Kronevi et al. 1977) or inhalation exposure in rats (Bonnet et al. 1980).
 
One unpublished study reported kidney damage following inhalation exposure
 
in rats [Dow Chemical Co. (cited in Torkelson and Rowe 1981)].
 
Renal effects in mice and dogs given intraperitoneal or subcutaneous
 
injections of 1,1,2-trichloroethane were studied in a series of experiments
 
by Plaa and co-workers. Although no gross effects were visible, tubular
 
lesions with necrosis were seen microscopically in the cortex of the kidneys
 
of mice injected subcutaneously with 173 mg/kg 1,1,2-trichloroethane (Plaa
 
et al. 1958). The ED50 for necrosis, swelling of the kidney, and renal
 






urine, was 216 mg/kg by intraperitoneal injection (Plaa and Larson 1965).
 
Klaassen and Plaa (1966, 1967a) found necrosis and reduced ability to
 
excrete intravenously-administered PSP (phenolsulfonphthalein) in the
 
kidneys of male mice and dogs given 1,1,2-trichloroethane intraperitoneally.
 
Female mice did not show this effect, even at lethal doses (Klaassen and
 
Plaa 1967b). This evidence strongly suggests a sex difference in
 
susceptibility to the renal effects of 1,1,2-trichloroethane in mice, but
 
the reason for this difference is not known.
 
There is good evidence that 1,1,2-trichloroethane is nephrotoxic when
 
parenterally administered in mice and dogs. There is also some evidence for
 
kidney effects in animals following inhalation and oral exposure. These
 
results suggest that 1,1,2-trichloroethane may be nephrotoxic in humans.
 
Immunological Effects. A detailed study of the effects of 1,1,2­
trichloroethane on the immune system was performed by Sanders et al. (1985).
 
They reported that significant effects on mouse immune function were found
 
at doses as low as 44 to 46 mg/kg/day in a 90-day study. Humoral immune
 
function, functional activity of the fixed macrophages of the
 
reticuloendothelial system, and macrophage phagocytic activity were all
 
affected (although the latter two were only altered in high-dose mice).
 
These data suggest that 1,1,2-trichloroethane may interfere with immune
 
function in animals. It is possible that these effects could also be
 
produced in humans exposed to 1,1,2-trichloroethane, although there are no
 
data currently available indicating immune system effects in humans.
 
There was a distinct sex difference in immune response to 1,1,2­
trichloroethane exposure in mice. Some effects, such as reduced spleen
 
lymphocyte response to lipopolysaccharide and increased vascular clearance
 
by the fixed macrophages of the reticuloendothelial system, were found only
 
in females. Others, such as depressed ability to phagocytize sheep red
 
blood cells, occurred only in males. The reason for these differences is
 
not known and their significance for human health is unclear.
 
Neurological Effects. Anesthesia has been produced in animals by oral
 
intake, inhalation, and intraperitoneal injection of 1,1,2-trichloroethane.
 
This effect has been studied in both mice and dogs. The ED50 for motor
 
impairment in mice reported by Borzelleca (1983) was approximately one third
 
the LD50 value for mice reported by White et al. (1985). At an inhalation
 
concentration of 3750 ppm, the ET50 (time required to produce anesthesia in
 
one-half of the treated animals) was 18 minutes, which is much less than the
 
LT50 of 10 hours in this study (Gehring 1968). The occurrence of anesthetic
 
effects at doses well below those that produce death indicates that 1,1,2­
trichloroethane is a potent CNS depressant.
 
Central nervous system depression was reported by De Ceaurriz et al.
 
(1981) following inhalation exposure in mice. Tham et al. (1984) found that
 
intravenous infusion of 28 mg/kg 1,1,2-trichloroethane had a depressive
 






represents a conditioned avoidance response, was another neurological effect
 
produced by 1,1,2-trichloroethane. Kallman et al. (1983) suggest that taste
 
aversion may be sensitive to the acute health effects of 1,1,2­
trichloroethane, but that it may not be useful in assessing delayed or
 
cumulative toxicity. No data on neurological effects of 1,1,2­
trichloroethane in humans were located, but the evidence in animals suggests
 




Genotoxic Effects. Data on the genotoxic effects of 1,1,2­
trichloroethane are presented in Tables 2-4 and 2-5. In vitro mutagenicity
 
assays were negative in Salmonella typhimurium and positive in Saccharomvces
 
cerevisiae. A cell transformation assay performed in the absence of
 
activation on mouse BALB/c-3T3 cells was negative. A test of DNA repair in
 
cultured rat hepatocytes was positive, but one in mouse hepatocytes was not
 
(Williams 1983). Adduct formation with calf thymus DNA occurred in vitro at
 
a significant rate (DiRenzo et al. 1982a). DNA adduct formation in vivo
 
occurred to a greater extent in mouse liver than in rat liver (Mazzullo
 
et al. 1986). The authors point out that there is a correlation between
 
these adduct formation results and species susceptibility to cancer, as the
 
incidence of hepatocellular carcinomas was increased in mice, but not rats,
 
given 1,1,2-trichloroethane for 78 weeks. Finally, DNA synthesis was
 
inhibited by intratesticular injection of 1,1,2-trichloroethane in the mouse
 
(Borzelleca 1983). Although there are negative as well as positive results,
 
it is evident that this compound does have some genetic effects both in
 
vitro and in vivo. The significance of these effects for humans is not
 




Cancer. There is no evidence for carcinogenicity of 1,1,2-trichloro­
ethane in humans. Among animals, 1,1,2-trichloroethane was carcinogenic in
 
B6C3Fl mice, but not Osbourne-Mendel rats. In a gavage study by NCI (1978),
 
this compound produced significant increases in the incidence of hepato­
cellular carcinomas and adrenal pheochromocytomas in mice. Based on
 
this study, Gold et al. (1987) calculated the carcinogenic potency (TD50) of
 
1,1,2-trichloroethane in mice to be 47.6 mg/kg/day, which is similar to the
 
value for chloroform and about one third the value for carbon tetrachloride.
 
No increase in the incidence of neoplasms was observed in rats under the
 
conditions of the NCI bioassay. Carcinogenicity in rats was also studied by
 
Norpoth et al. (1988), who found that subcutaneous injection of 15.4 or 46.8
 
µmol of 1,1,2-trichloroethane in DMSO once a week for 2 years had no effect 
on the incidence of benign mesenchymal and epithelial tumors in Sprague-
Dawley rats. The incidence of sarcomas (mostly localized on the 
extremities) increased with dose in both sexes and was significantly 
elevated in high-dose rats compared to untreated controls. However, the 
lack of any sarcomas in the untreated controls was unusual for this strain, 
and when compared to the spontaneous incidence of sarcomas reported in the 
literature, this effect was no longer significant. In addition, sarcoma 







limited evidence in mice, 1,1,2-trichloroethane has been classified in
 
Group C as "a possible carcinogen" (EPA 1988a).
 
The mechanism of 1,1,2-trichloroethane carcinogenicity in mice is not
 
known. Metabolism of this compound involves formation of acyl chlorides and
 
free radicals, which may play a role in cancer formation. Although 1,1,2­
trichloroethane has not been shown to be carcinogenic in rats, a study of
 
cancer initiation and promotion in this species was located. Story et al.
 
(1986) gave a single oral dose of 1,1,2-trichloroethane at 69 mg/kg in corn
 
oil to rats and followed this treatment with 8 weeks administration of
 
phenobarbital, a promoter of hepatocellular carcinomas. Using liver foci
 
with altered enzyme levels as pre-neoplastic markers, they found no evidence
 
that 1,1,2-trichloroethane acted as an initiator. The reciprocal
 
experiment, using diethylnitrosamine (DEN) as the initiator and 1,1,2­
trichloroethane as the possible promoter, gave similar results whether or
 
not DEN initiation was given. In either case, there was a large increase in
 
the total number of liver foci. However, when examined more closely, it was
 
found that these increases occurred solely in the number of Type II foci,
 
which do not appear to be preneoplastic. Therefore, no evidence of cancer
 
promotion by 1,1,2-trichloroethane was found in this study.
 
2.4 LEVELS IN HUMAN TISSUES AND FLUIDS ASSOCIATED WITH HEALTH EFFECTS
 
No studies were located regarding the levels of 1,1,2-trichloroethane
 
in human tissues and fluids associated with effects.
 




The levels of 1,1,2-trichloroethane were studied in 230 personal air
 
samples, 170 drinking water samples, 66 breath samples and 16 food samples
 
from 9 volunteers in New Jersey and 3 in North Carolina (Wallace et al.
 
1984). In 99% of the cases, no 1,1,2-trichloroethane or only trace amounts
 
were found in the environment, or in the exhaled breath of the people.
 
Specifically, the personal air concentrations of 1,1,2-trichloroethane were
 
below the detection limit in 151/161 samples, 7 contained trace levels, and
 
the others had a very low median value of 0.35 µg/m3 (0.063 ppb). Breath 
samples were negative in 44/49 samples, value of 0.2 µg/m3 (0.036 ppb). 
and the others had a very low median 
The levels of halogenated organic compounds were studied in the Ruhr
 
region of West Germany from 1976-1978 (Bauer 1981a,b). The concentration of 
1,1,2-trichloroethane in the Rhine river at this time averaged 0.2 µg/L 
(ppb), and the concentration in the drinking water in 100 German cities had 
a maximum of 5.8 µg/L (ppb). Air concentrations rarely were over 1 µg/m3 
(0.18 ppb) and 1,1,2-trichloroethane was not detected in the foods or
 
cosmetic products available locally. The average concentrations in humans
 
tissues studied in 15 people who were exposed primarily via the air (94% of
 





subdermal adipose tissue, 2 µg/kg in the lungs, 3 µg/kg in the liver, and 17 
µg/kg in the muscle tissue. This study does not establish levels in human 







Studies in humans indicate that 1,1,2-trichloroethane is absorbed
 
rapidly after inhalation exposure (Morgan et al, 1970, 1972). A volunteer
 
took one breath of radiolabeled 1,1,2-trichloroethane and expired 10% of
 
the inspired dose in the alveolar air after 12 seconds and about 0.5% after
 
40 seconds of breath-holding. More than 90% of the administered dose was
 
retained in the body after 50 minutes. These data indicate that 1,1,2­
trichloroethane was extensively absorbed into the bloodstream.
 
The only data on absorption of 1,1,2-trichloroethane following
 
inhalation exposure in animals comes from the assumption that an
 
administered chemical has been absorbed by the body if it can be shown to
 
affect physiological processes. 1,1,2-Trichloroethane has been shown to
 
affect the exhalation of acetone in rats (Filser et al. 1982), so it can be
 




No studies were located regarding absorption in humans following oral
 
exposure to 1,1,2-trichloroethane. The only data available in animals
 
showed that oral doses near the MTD (maximum tolerated dose) in mice (300
 
mg/kg) or rats (70 mg/kg) were 81% metabolized, indicating that at least
 
this amount was absorbed (Mitoma et al. 1985). This suggests that 1,1,2­
trichloroethane, like other structurally related halocarbons, is well
 






No studies were located regarding absorption in humans following dermal
 
exposure to 1,1,2-trichloroethane. Two studies in animals indicate that
 
1,1,2-trichloroethane is easily absorbed through the skin. In the guinea
 
pig, blood concentration of 1,1,2-trichloroethane peaked at ≈3.7 µg/mL 
within a half-hour following 1,1,2-trichloroethane application to the skin 
(Jakobson et al. 1977). Following the peak, the blood level declined to 
≅2.5 µg/L at 1 hour, remained at this level until ≅4 hours, and then rose to 
≅3.7 µg/L at 6 hours. The authors suggested that this complex dermal 
absorption of 1,1,2-trichloroethane may be due to an initial increased 
barrier function of the skin after 1. hour, which led to decreased 





an overcoming of the barrier. In mice, 15 minutes after application of 0.5
 
ml of 1,1,2-trichloroethane, 99.7% was retained in the body and 0.3% was
 
expired in the breath (Tsuruta 1975). The absorption rate was calculated to
 
be 130 nmoles/min/cm2 of skin. The rapid absorption through the skin may
 
well be due to the highly lipid soluble character of 1,1,2-trichloroethane
 






No studies were located regarding distribution in humans following
 
inhalation of 1,1,2-trichloroethane. After an inhalation exposure of 1000
 
ppm for 1 hour, 1,1,2-trichloroethane was distributed in mice organs in the
 
following manner: approximately 600 µg/g in fats, 80 µg/g in the kidney and 
liver, 45-60 µg/g in the blood and brain, and 20-35 µg/g in the heart, 
spleen and lung (Takahara 1986a). Examination of partition coefficients 
showed that 1,1,2-trichloroethane had a moderate degree of lipid solubility 
compared to other hydrocarbons, but was still quite lipid soluble (Gargas et 
al. 1989, Imbriani et al. 1985, Morgan et al. 1972, Sato and Nakajima 1979). 
This indicates that 1,1,2-trichloroethane could be easily distributed and 
retained in fat, liver, and brain in both animals and humans. 
2.6.2.2 Oral Exposure
 
No studies were located regarding distribution in humans or animals
 
following oral exposure to 1,1,2-trichloroethane. One study showed that
 
1,1,2-trichloroethane was distributed to the liver following oral exposure
 
in animals (Mitoma et al. 1985). In this study, 1,1,2-trichloroethane was
 
extensively metabolized (presumably by the liver), and was also found to
 
bind hepatic protein. It is likely that 1,1,2-trichloroethane is also
 




No studies were located regarding distribution in humans or animals
 








The primary metabolites identified by high-performance liquid
 
chromatography in rats and mice given 1,1,2-trichloroethane by gavage were
 
chloroacetic acid, S-carboxymethylcysteine, and thiodiacetic acid (Mitoma et
 
al. 1985). An earlier study reported these three compounds to be the
 
primary metabolites of 1,1,2-trichloroethane following intraperitneal
 






formed from 1,1,2-trichloroethane following conjugation with glutathione
 
(Yllner 1971). Chloroacetic acid is formed by hepatic cytochrome P-450
 
(Ivanetich and Van Den Honert 1981). This reaction is thought to proceed
 
via the acyl chloride. Cytochrome P-450 can also produce free radicals from
 
1,1,2-trichloroethane (Mazzullo et al. 1986). These proposed pathways are
 
shown in Figure 2-4. Acyl chlorides and free radicals are reactive
 
metabolites that can bind to proteins and nucleic acids, and are suspected
 
of being cytotoxic, mutagenic, and carginogenic (Ivanetich and Van Den
 
Honert 1981, Mazzullo et al. 1986). Other metabolites, found only in trace
 
amounts in mice and rats following exposure to 1,1,2-trichloroethane,
 
included trichloroacetic acid and trichloroethanol (Ikeda and Ohtsuji 1972,
 
Takahara 1986b, Yllner 1971). It is not clear how these compounds were
 
formed; it was suggested by Yllner (1971) that they might be derived from
 
impurities in the 1,1,2-trichloroethane samples used.
 
Although percent of the orally-administered dose metabolized was
 
identical in rats and mice (81%), the actual amount of 1,1,2-trichloroethane
 
metabolized was much higher in mice (Mitoma et al. 1985). The chemical was
 
given to each species at the MTD, which was 4.3 times greater in mice; mice
 
experienced a higher body burden than rats, but were able to metabolize the
 
same percentage of it. The inherent ability of mice to metabolize 1,1,2­
trichloroethane at a higher rate than rats may contribute to the greater
 
susceptibility of mice to 1,1,2-trichloroethance cytotoxicity and
 
carcinogenity. It is not known how the rate of 1,1,2-trichloroethane
 
metabolism in humans compares to that in mice and rats. Metabolism in
 






The excretion rate of inhaled 1,1,2-trichloroethane in humans was
 
measured in the breath and urine of humans (Morgan et al. 1970). Excretion
 
in the breath after 1 hour was 2.9% of the administered dose; the slope of
 
the retention curve was 0.006. The excretion rate in the urine was less
 
than 0.0l%/min of administered radioactivity. From these data, the half-

life for urinary excretion was estimated to be about 70 minutes.
 
The half-life following l-hour inhalation exposure to 1005 ppm of
 
1,1,2-trichloroethane in mice was determined to be 625 minutes in the heart,
 
203 minutes in the fat, 147 minutes in the brain, 127 minutes in the spleen,
 
122 minutes in the lungs, 43 minutes in the kidney, 39 minutes in the blood,
 
and 19 minutes in the liver (Takahara 1986a). The half-life in the whole
 
body was calculated to be 49.3 minutes. The presence of 1,1,2­













The excretion routes were shown to be similar in rats and mice,
 
regardless of whether the chemical was given orally (Mitoma et al. 1985) or
 
intraperitoneally (Yllner et al. 1971). Following a dose of radiolabeled
 
compound, about 7-10% of 1,1,2-trichloroethane was exhaled unchanged in the
 
breath, 3-7% was exhaled as C02, 72%-87% was found as metabolites in the
 
urine, about 1% was in the feces, and l-3% remained in the carcasses of rats
 
and mice after 48 hours. The excretion from humans is also likely to be
 




No studies were located regarding excretion in humans or animals
 
following dermal exposure to 1,1,2-trichloroethane.
 
2.7 INTERACTIONS WITH OTHER CHEMICALS
 
Polybrominated biphenyls (PBBs) were shown to increase the renal
 
toxicity of 1,1,2-trichloroethane as measured by decreases in paminohippurate
 
accumulation in renal cortical slices (Kluwe et al. 1978).
 
PBBs are known to increase the activities of microsomal mixed-function
 
oxygenases in the kidney and liver, so increased metabolism of 1,1,2­
trichloroethane and the increased presence of metabolites more toxic than
 
the parent compound itself may be responsible for the increased toxicity of
 
1,1,2-trichloroethane in the kidney. However, the study also showed that
 
PBBs did not increase the hepatotoxic effects of 1,1,2-trichloroethane, as
 
indicated by relative liver weight or SGOT levels.
 
Phenobarbital, another microsomal enzyme inducing agent, was found to
 
potentiate liver toxicity, as indicated by increases in SGOT and SGPT in
 
rats that were exposed to 1,1,2-trichloroethane vapor (Carlson 1973).
 
Guinea pigs treated with pentobarbital as an anesthetic following dermal
 
application of 1,1,2-trichloroethane were shown to have reduced glycogen
 
levels and hydropic changes in the liver (Kronevi et al. 1977). Liver
 
effects were not found in anesthetized "control" animals or animals that
 
were treated with 1,1,2-trichloroethane, but not anesthetized. The authors
 
suggest that the liver effects they observed were produced by the
 
interaction of pentobarbital and 1,1,2-trichloroethane. The lack of
 
untreated controls makes this claim difficult to evaluate, however.
 
Potentiation is usually seen only after pretreatment with the inducer, since
 
time is required for enzyme induction. It may be that dermal absorption of
 
1,1,2-trichloroethane was slow enough, compared to intraperitoneal
 






Pretreatment with low, but not high doses of acetone (MacDonald et al.
 
1982) potentiated the hepatotoxicity of 1,1,2-trichloroethane in rats as
 
indicated by a rise in SGPT and a decrease in hepatic GSH levels. Acetone
 
also potentiated the 1,1,2-trichloroethane-induced elevation of SGPT in mice
 
(Traiger and Plaa 1974).
 
Pretreatment with isopropyl alcohol (Traiger and Plaa 1974) or ethanol
 
(Klaassen and Plaa 1966) potentiated the 1,1,2-trichloroethane-induced
 
elevation of SGPT activity in mice. Pretreatment with ethanol did not alter
 
BSP retention (Klaassen and Plaa 1966).
 
Pretreatment with alloxan, which induces a hyperglycemic state similar
 
to that found in diabetic humans, also enhanced the hepatotoxic effects of
 
1,1,2-trichloroethane in rats as indicated by increased SGPT activity and
 
increased hepatic triglyceride concentration (Hanasono et al. 1975). The
 
mechanism of this interaction is unknown.
 
2.8 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
 
Persons with diabetes (Hanasono et al. 1975), or with prior exposure to
 
PBBs (polybrominated biphenyls) (Kluwe et al. 1978), or with prior exposure
 
to isopropyl or ethyl alcohol or acetone (Traiger and Plaa 1974) may be more
 
susceptible to the hepatotoxic effects of 1,1,2-trichloroethane. Prior
 




2.9 ADEQUACY OF THE DATABASE
 
Section 104(i)(5) of CERCLA, directs the Administrator of ATSDR (in
 
consultation with the Administrator of EPA and agencies and programs of the
 
Public Health Service) to assess whether adequate information on the health
 
effects of DCE is available. Where adequate information is not available,
 
ATSDR, in cooperation with the National Toxicology Program (NTP), is
 
required to assure the initiation of a program of research designed to
 
determine these health effects (and techniques for developing methods to
 
determine such health effects). The following discussion highlights the
 
availability, or absence, of exposure and toxicity information applicable to
 
human health assessment. A statement of the relevance of identified data
 
needs is also included. In a separate effort, ATSDR, in collaboration with
 




2.9.1 Existing Information on Health Effects of Trichloroethane
 
Existing studies on the health effects of 1,1,2-trichloroethane are
 
shown in Figure 2-5. Almost no data exist for the health effects of this
 
compound in humans; a single study on the dermal irritation of 1,1,2­







The health effects of 1,1,2-trichloroethane in animals have been fairly
 
well studied. A number of inhalation studies investigated lethality in rats
 
and mice, and several made LC50 determinations. The systemic effects that
 
have been studied following inhalation exposure are liver and kidney
 
effects. Liver effects were investigated in several studies that measured
 
serum transaminase levels and other biochemical endpoints; only one
 
unpublished study included histopathological examination of the liver. The
 
same study included histopathological examination of the kidney. This
 
study was also the only one in which animals were repeatedly exposed to
 
1,1,2-trichloroethane vapor; all other studies by this route were single
 
exposure tests. Neurological effects following inhalation were studied by
 




Following oral exposure, lethality in rats, mice, and dogs has been
 
reported. LD50 values were calculated for the first two species. Systemic
 
effects were studied in rats, mice, and dogs using biochemical and
 
histopathological measures. Most studies were of single exposures, but
 
there was one study of intermediate duration (which did not include
 
histopathological examination) and one of chronic duration (which included
 
only histopathologic examination). Immunological effects were reported in a
 
study that included tests of humoral and cell-mediated immune function.
 
Neurological effects were studied by behavioral observation and, in longerterm
 
studies, examination of tissues. Developmental toxicity was the
 
subject of one study that did not include examination of fetuses for
 
malformations. Data on reproductive effects come from this study and
 
longer-term studies that examined reproductive tissues, but did not perform
 
tests of reproductive function. Carcinogenicity was studied in one 78-week
 
bioassay in rats and mice and one 2-year study in rats that was not,
 
however, performed by a relevant route of exposure.
 
There is one study of lethality in guinea pigs following dermal
 
exposure to 1,1,2-trichloroethane. There are also several studies of skin
 
and eye irritation in dermally-exposed animals. One poorly-designed study
 
investigated the effect of dermally applied 1,1,2-trichloroethane on liver,
 




Single Dose Exposure. Tests of the acute toxicity of 1,1,2­
trichloroethane administered orally and by inhalation have provided
 
information on 1,1,2-trichloroethane exposure levels that produce liver and
 
kidney damage, neurological effects, and death in animals. Several of these
 
studies included analyses for subtle liver effects, but few included
 
histopathological examinations. More studies which carefully examine liver
 
and other tissues histologically and look for subtle effects on other organs
 
may be beneficial. They might provide information on mechanisms by which
 
1,1,2-trichloroethane produces lethality and neurological effects and
 






is helpful to understanding the health effects of a chemical. Dermal
 
studies of 1,1,2-trichloroethane have provided information on exposure
 
levels that produce skin irritation in humans and animals and death in
 
animals. One poorly-designed study attempted to investigate systemic
 
effects in dermally exposed animals. A study of systemic toxicity following
 




Repeated Dose Exposure. Only one study examined the health effects of 14­
and 90-day ingestion of 1,1,2-trichloroethane in drinking water of
 
animals, and it did not include histopathological examinations. A
 
subchronic oral study with complete histological examination would be
 
useful. Repeated dose exposure by inhalation was examined only in an
 
unpublished report that could not be obtained for review. A published
 
report of this study or a replacement would provide useful information.
 
Repeated dermal application of 1,1,2-trichloroethane to humans was done in
 
one study. No effects were found, but the irritancy of 1,1,2­
trichloroethane in single-dose exposure tests suggests that repeated-

exposure dermal tests in animals would provide meaningful information.
 
Chronic Exposure and Carcinogenicity. A 78-week bioassay on orally
 
administered 1,1,2-trichloroethane was performed in rats and mice by the
 
National Cancer Institute. 1,1,2-Trichloroethane was found to be cancerous
 
in mice, but not rats. The 78-week dosing period is no longer considered
 
adequate for rats. Current studies of this type use exposure durations of
 
approximately 2 years. A 2-year study was conducted by Norpoth et al.
 
(1988), but exposure was by subcutaneous injection, which is not a relevant
 
route. Two-year studies by the oral and inhalation routes on rats and mice
 
using several doses, examining endpoints of hematology, clinical chemistry,
 
urinalysis, and performing microscopic examination of tissues may provide
 
valuable dose-response data and identify more subtle indicators of toxicity.
 




Genotoxicity. The available genotoxicity studies indicate that 1,1,2­
trichloroethane is not mutagenic in bacteria, but may interact with
 
mammalian DNA in vivo. Chromosomal aberration and micronucleus tests on
 
1,1,2-trichloroethane were not located. Additional genotoxicity tests would
 
help to determine whether 1,1,2-trichloroethane is genotoxic in humans.
 
Reproductive Toxicity. Several studies included examination of
 
reproductive organs and tissues following exposure to 1,1,2-trichloroethane,
 
but found no effects. One study designed to look at developmental toxicity
 
reported no effect on reproductive endpoints. Studies in which animals
 
exposed to 1,1,2-trichloroethane are mated and their offspring observed
 







Developmental Toxicity. A study on the developmental toxicity of
 
1,1,2-trichloroethane in mice found no effect, but it did not include
 
examination of the fetuses for malformations. A complete teratology study
 
in two species would provide better information on the developmental
 
toxicity of 1,1,2-trichloroethane in animals and help to determine whether
 




Immunotoxicity. The immunological effects of 1,1,2-trichloroethane
 
have been studied following 14-day and 90-day oral exposure. Several
 
measures of both humoral and cell-mediated immune response were investigated
 
in this study, and some positive results were found. The fact that effects
 
were found in some tests, but not others intended to measure the same
 
response, indicates that more studies of this type could provide worthwhile
 
information. In addition, immune responses were different in male and
 
female mice, and investigation of these differences might provide meaningful
 




Neurotoxicity. Studies of 1,1,2-trichloroethane in animals have
 
provided information on the neurological effects produced by acute exposure
 
to 1,1,2-trichloroethane, and the levels at which they occur. The results
 
of one study suggested that taste aversion may be a sensitive indicator of
 
the acute neurological effects of 1,1,2trichloroethane. Additional
 
neurobehavioral tests may reveal still more sensitive neurologic endpoints
 
or provide support for use of taste aversion as an indicator of neurologic
 
effects. Repeated exposure studies involved examination of neurological
 
organs and tissues, but no tests of neurological function. Reliable studies
 
of neurotoxicity by dermal exposure do not exist.
 
Epidemiological and Human Dosimetry Studies. No human studies were
 
found in the literature which relate exposure to 1,1,2-trichloroethane with
 
health effects. The evidence in animals, however, indicates that 1,1,2­
trichloroethane can have effects on the nervous system, immune system, and
 
liver and kidney function, and can be lethal. It is also carcinogenic in
 
mice. These effects may also occur in humans, if they are exposed to appropriate
 
levels of 1,1,2-trichloroethane. Epidemiological and human dosimetry studies might
 




Biomarkers of Disease. No studies were located that identified
 
biomarkers specific for 1,1,2-trichloroethane-induced disease states. If
 
epidemiological studies are performed that associate effects with exposure,
 
it may be possible to identify alterations in blood chemistry indices or
 
other pathological endpoints that would be useful to identify the disease
 
state. Biomarkers for diagnosis of target organ toxicity (e.g., SGOT for
 
liver damage) can provide useful information in conjunction with specific
 






Disease Registries. Currently, no human disease states are associated
 
with exposure to 1,1,2-trichloroethane. If future studies identify
 
particular diseases produced by 1,1,2-trichloroethane, it may be possible to
 
determine the number of people affected and the factors associated with the
 
development of the disease, such as involvement of populations in certain
 
occupations or living in certain areas.
 
Bioavailability from Environmental Media. Since 1,1,2-trichloroethane is
 
expected to exist in the atmosphere as the vapor rather than adsorb toparticulate
 
matter, there would not be a competing adsorption that would impede its
 
bioavailability via the lungs. Limited data showing the presence of 1,1,2­
trichloroethane in adipose and other tissue of exposed subjects indicate that
 
1,1,2-trichloroethane is taken up via the lungs, GI tract or both. A pilot study
 
demonstrated that similar low molecular weight chlorinated alkanes are found in
 
human milk (Pellizzari et al. 1982). The source of these pollutants was probably
 




Food Chain Bioaccumulation. 1,1,2-Trichloroethane has not been
 
reported in food or biota, nor were any studies located in which the levels
 
of this chemical in plants or animals were reported. The bioaccumulation
 
potential for a chemical is most conveniently studied by measuring the
 
bioconcentration factor (BCF) or the concentration of a chemical in fish
 
divided by the concentration in water from which the chemical is taken up.
 
The BCF of 1,1,2-trichloroethane in fish is reported to be <10 (Kawasaki
 
1980), indicating a very low potential for bioaccumulation in the food
 
chain. Experimental verification of the lack of food chain bioaccumulation
 
is not available. Such information can be obtained by studying the
 
accumulation of 1,1,2-trichloroethane in organisms from different trophic
 
levels that have been exposed to the chemical.
 
Absorption, Distribution, Metabolism, Excretion. Little information is
 
available regarding the toxicokinetics of 1,1,2-trichloroethane in humans or
 
animals. Information on absorption in humans comes from a brief study using two
 
volunteers; the only information from animals is inferred from the fact that
 
administration of 1,1,2-trichloroethane via the inhalation or oral routes causes
 
toxic effects. Animal studies which specifically test the amount and rate of
 
absorption of 1,1,2-trichloroethane would provide information as to how much
 
1,1,2-trichloroethane humans might be likely to absorb from various routes of
 
exposure. For distribution, the only human data are from one briefly reported
 
study, and the only animal data are from one acute study. More extensive and
 
longer-term animal studies using the inhalation, oral or dermal routes would help
 
determine 1,1,2-trichloroethane distribution in the body. For metabolism, more
 
animal studies would be helpful in, showing what kind of metabolites might be
 
expected to be found in the blood or urine of humans; if these could be measured,
 
they might give an indication of amount of exposure to 1,1,2-trichloroethane.
 






definitive information on mechanfsms of 1,1,2-trichloroethane toxicity and
 
carcinogenicity. Data on excretion are fairly complete.
 
Comparative Toxicokinetics. No studies were located which compared
 
human and animal toxicokinetics. Two comparative toxicokinetics studies
 
were performed which examined the differences between rats and mice in the
 
types of metabolites formed, and the excretion rates from various routes.
 
Although percent of administered dose metabolized was similar in both
 
species, the overall rate of metabolism of 1,1,2-trichloroethane was greater
 
in mice (Mitoma et al. 1985). The same metabolites were formed in the same
 
proportions in both species. The difference in metabolic rate may be
 
related to species differences in susceptibility to the toxic effects of
 
1,1,2-trichloroethane. More studies of this type could corroborate this
 






No on-going studies were located regarding health effects or
 









Data pertaining to the chemical identity of 1,1,2-trichloroethane
 
are listed in Table 3-1,
 
3.2 PHYSICAL AND CHEMICAL PROPERTIES
 
The physical and chemical properties of 1,1,2-trichloroethane are
 











1,1,2-Trichloroethane is produced by Dow Chemical U.S.A. in Freeport,
 
TX and by Olin Corporation in Seward, IL (SRI 1988). No production figures
 
are available. It is produced in the U.S. from ethylene. In one method of
 
preparation, ethylene is chlorinated to give 1,2-dichloroethane, which is
 
then reacted with chlorine to give 1,1,2-trichloroethane (Archer 1979). A
 
second method is via the oxychlorination of ethylene with hydrogen chloride
 
and oxygen at 280-37°C in the presence of a catalyst (Archer 1979). 1,2­
Dichloroethane and higher chlorinated ethanes are also formed in this 
process. 1,1,2-Trichloroethane is also produced as a coproduct in the 
thermal chlorination of l,l-dichloroethane to produce l,l,l-trichloroethane, 
especially when the reaction is carried out in the liquid phase (Archer 
1979). 
The only information pertaining to the amount of 1,1,2-trichloroethane
 
produced dates back to 1979, when it was estimated that approximately 412
 
million pounds were produced (Thomas et al. 1982). This figure is the
 
quantity of 1,1,2-trichloroethane required for maximum potential production
 
of l,l-dichloroethene (vinylidene chloride) and may be an overestimate
 
because l,l-dichloroethene can also be produced from l,l,l-trichloroethane
 
(Thomas et al. 1982). The exact quantity manufactured is proprietary
 
information of Dow Chemical Corporation, who was the sole producer of 1,1,2­
trichloroethane at that time. Most of the chemical was captively consumed
 
as a precursor for 1,1-dichloroethene, however according to a spokesperson
 
from Dow a quantitity said to be in the 'low millions of pounds' is used
 
annually in other industries (Thomas et al. 1982). It is not known whether
 
the consumption of 1,1,2-trichloroethane has changed appreciably since 1979.
 
1,1,2-Trichloroethane is sometimes present as an impurity in commercial
 
samples of l,l,l-trichloroethane and trichloroethylene (Henschler et al.
 
1980; Tsuruta et al. 1983). 1,1,2-Trichloroethane has been shown to be
 
formed during the anaerobic biodegradation of 1,1,2,2-tetrachloroethane;
 
anaerobic conditions may occur in groundwater or in landfills (Bouwer and
 




Data pertaining to the import of 1,1,2-trichloroethane were not located
 




The principal use of 1,1,2-trichloroethane is as a chemical
 
intermediate in the production of l,l-dichloroethene (Archer 1979). There
 
is no information available on the uses of the 'low millions of pounds' that
 




4. PRODUCTION, IMPORT, USE, AND DISPOSAL
 
1,1,2-Trichloroethane finds limited use as a solvent where its high solvency
 
is needed, such as for chlorinated rubbers (Archer 1979). It may be used as
 
a solvent for fats, oils, waxes, and resins (Hawley 1981). Some 1,1,2­
trichloroethane was sold for use in consumer products (Thomas et al. 1982).
 
There was no indication in the literature as to what these products were.
 
Moolenaar and Olson (1989), in a written communication as spokesmen for the
 
Dow Chemical Company, a major producer of 1,1,2-trichloroethane, however,
 
stated that they are not aware of any consumer uses and that the Dow
 






1,1,2-Trichloroethane has been disposed of by adsorption on a suitable
 
sorbent such as vermiculite, dry sand, or earth and placement in a secure
 
landfill (NLM 1988). This method is not recommended, however (NLM 1988),
 
although no alternative method was discussed in the available literature.
 








Data on current production and use of 1,1,2-trichloroethane are
 
completely inadequate. Information is especially needed on the commercial
 
uses of 1,1,2-trichloroethane and what types of consumer products, if any,
 
contain this chemical. This information is essential for estimating
 
exposure to 1,1,2-trichloroethane and for determining which groups in the
 
population are occupationally or generally exposed. According to the
 
Emergency Planning and Community Right to Know Act of 1986 (EPCRTKA),
 
(§313), (Pub. L. 99-499, Title III, §313), industries are required to submit
 
release information to the EPA. The Toxic Release Inventory (TRI), which
 
contains release information for 1987, became available in May of 1989.
 
This database will be updated yearly and should provide a more reliable
 








1,1,2-Trichloroethane is predominantly a man-made chemical whose
 
presence in the environment results from anthropogenic activity. This
 
chemical has also been identified as an intermediate in the biodegradation
 
of 1,1,2,2-tetrachloroethane, another man-made chemical. It is made
 
commercially by the chlorination of ethylene with chlorine or by the
 
oxychlorination of ethylene with HCl and oxygen. It is primarily used as a
 
captive intermediate in the manufacture of 1,1-dichloroethene (vinylidene
 
chloride), but may also be used as a solvent, especially in chlorinated
 
rubber manufacture. Production and use information are proprietary, however
 
effluent monitoring data indicate that high levels (>100 ppb) of discharge
 
are associated with laundries, and the organic chemicals and mechanical
 
products industries (Table 5-l). The maximum levels in these waste-waters
 
were 109-250 ppb. Gaseous releases include vent gas and fugitive
 
emissions from the production and use of 1,1,2-trichloroethane as well as
 
volatilization from wastewater and municipal treatment plants. Releases to
 
soil are expected to involve the landfilling of sludge and process residues.
 
Thus far, 1,1,2-trichloroethane has been found at 45 of 1177 hazardous waste
 
sites on the National Priorities List (NPL) in the United States (VIEW
 
Database 1989). Based on the release pattern of other chlorinated ethanes
 
and ethenes, it is expected that the release pattern for 1,1,2­
trichloroethane is 70-90% to air, l0-30% to land, and a few percent to
 




If 1,1,2-trichloroethane is released into soil, it is expected to
 
partially leach into the subsurface and groundwater (because it has a low
 
soil adsorption coefficient), and to partially volatilize. In groundwater,
 
it will be subject to anaerobic biodegradation, however no information
 
concerning reaction rates is available. Biodegradation is expected to occur
 
in sediment and landfills when anaerobic conditions are present. The
 
mechanism for biodegradation is reductive dehalogenation, which leads to the
 
formation of vinyl chloride, a human carcinogen (USDHHS 1985). From the
 
limited data available, biodegradation under aerobic conditions, such as
 
exists in surface soil, will be very slow, at best. In surface water,
 
volatilization is the primary fate process (half-life 4.5 hr in a model
 
river). Adsorption to sediment, bioconcentration in aquatic organisms,
 
aerobic biodegradation, and hydrolysis are thought to be negligible by
 
comparison. In the atmosphere, the dominant removal process is expected to
 
be oxidation by photochemically-generated hydroxyl radicals, which proceeds
 
by H-atom abstraction (estimated half-life 49 days). The radical so
 
produced subsequently reacts with atmospheric oxygen and other atmospheric
 
species. Removal from the atmosphere is also thought to occur from washout
 
by precipitation; however, most of the 1,1,2-trichloroethane removed by this
 
process is expected to reenter the atmosphere by volatilization. Because
 





5. POTENTIAL FOR HUMAN EXPOSURE
 
1,1,2-trichloroethane from source areas would be expected to occur. Thus,
 
it is conceivable that 1,1,2-trichloroethane could be transported from other
 
countries where it may be more widely used.
 
The general population may be exposed to low levels of 1,1,2­
trichloroethane through inhalation of contaminated ambient air. Limited
 
monitoring data suggest that roughly one-quarter to one-half of the urban
 
population may be so exposed. Where 1,1,2-trichloroethane is found, levels
 
appear to be about l0-50 ppt. Results from a nationwide monitoring study
 
of groundwater supplies show that exposure to 1,1,2-trichloroethane from
 
contaminated drinking water appears to be uncommon (Westrick et al. 1984).
 
However, in a New Jersey survey, 6.7% of the wells contained detectable
 
levels of 1,1,2-trichloroethane; the most polluted wells being associated
 
with urban land use (Page 1981; Greenberg et al. 1982). It is difficult to
 
assess occupational exposure because data on current production and use are
 
unavailable. A National Occupational Exposure Survey (NOES) by the National
 
Institute of Occupational Safety and Health (NIOSH) through May 1988,
 
estimates that 1,036 employees are potentially exposed to 1,1,2­








1,1,2-Trichloroethane is emitted in vent gas when produced by the
 
oxychlorination of ethylene dichloride (Liepins et al. 1977). Environmental
 
releases of 1,1,2-trichloroethane from l,l-dichloroethene manufacture are
 
small; an EPA study found no 1,1,2-trichloroethane in process vent gas
 
(Thomas et al. 1982). 1,1,2-Trichloroethane is formed in small quantities
 
and may be released in vent gas or fugitive emissions during the production
 
of other chlorinated hydrocarbons, for example, 1,2-dichloroethane and
 
l,l,l-trichloroethane (Thomas et al. 1982). Fugitive emission from its use
 
as a solvent and volatilization from wastewater constitute the major
 
environmental release of 1,1,2-trichloroethane. An estimate of the total
 
release of 1,1,2-trichloroethane was made for 1979 by comparing ambient
 
levels of l,l,l-trichloroethane and 1,1,2-trichloroethane in urban air and
 
releases of l,l,l-trichloroethane (Thomas et al. 1982). The annual amount
 
of 1,1,2-trichloroethane released annually was calculated to be 10,000­
20,000 million tons.
 
A correlation of data from the EPA Air Toxics Emission Inventory with
 
industrial source categories (SIC codes), shows that volatile emissions of
 
1,1,2-trichloroethane are associated with plastic materials and resins,
 
industrial organic chemicals, petroleum refining, gaskets-packing and
 
sealing devices, plating and polishing, residential lighting fixtures, radio
 
and TV communication equipment, electronic components, motor vehicles parts
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equipment and supplies (SIC Codes 2821, 2869, 2911, 3293, 3471, 3645, 3662,
 
3679, 3714, 3811, 3861) (EPA 1987a).
 
1,1,2-Trichloroethane was found at hazardous waste sites that are
 
included in the National Priorities List (NPL). Volatile organic compound
 
(VOC) emissions are observed at solid waste landfills (these emissions are
 
2.6-times greater in a wet climate than a dry one (Vogt et al. 1987)).
 
Therefore low levels of 1,1,2-trichloroethane may be expected in landfill
 




Wastewater streams from the production of 1,1,2-trichloroethane by
 
liquid-phase chlorination of ethylene dichloride and the oxychlorination of
 
ethylene dichloride with HCl contain 1,1,2-trichloroethane (Liepins et al.
 
1977). Information on industries that discharge 1,1,2-trichloroethane, the
 
frequency of discharge, and concentration levels can best be obtained from
 
the results of a comprehensive wastewater survey conducted by the Effluent
 
Guidelines Division of the EPA shown in Table 5-l. Over 4000 samples of
 
wastewater from a broad range of industrial facilities and publicly-owned
 
treatment works were analyzed in this survey. While the percentage of
 
industries in a particular category containing 1,1,2-trichloroethane or the
 
volume of wastewater generated by them was not indicated, the data suggest
 
that significant amounts of 1,1,2-trichloroethane are released into
 
waterways nationwide (see Table 5-l). Between 1980 and 1988, 707 samples of
 
wastewater in EPA's STORET database were analyzed for 1,1,2-trichloroethane
 
(STORET 1988). Ten percent of the samples contained 10 parts per billion
 
(ppb) or higher concentrations of 1,1,2-trichloroethane and the maximum
 
level obtained was 360 ppb. Unfortunately, the detection limit is
 
apparently recorded when no chemical is detected, so it is impossible to say
 
whether the 90 percentile figure represents positive samples or merely
 
higher detection limits. EPA investigated priority pollutants in 40
 
geographically distributed publicly-owned treatment works (POTWs)
 
representing a variety of municipal treatment technologies, size ranges, and
 
industrial flow conditions. In this study, 1,1,2-trichloroethane was
 
detected in 7% of influent samples, 3% of effluent samples, and 4% of raw
 




1,1,2-Trichloroethane was found at concentrations of 2.1, 26, and 180
 
ppb in three outfalls from the Dow Chemical of Canada plant into the St.
 
Clair River for a net loading of 3.5 kg/day (King and Sherbin 1986).
 
Puddles containing chlorinated hydrocarbons had been discovered on the
 
bottom of the St. Clair River, which received these effluents (King and
 
Sherbin 1986; Kaiser and Comba 1986). These chemicals are thought to be
 
products or byproducts of chlorinated hydrocarbons manufactured at this
 
site. Waste from this operation is now being incinerated but was
 
historically landfilled. Landfill leachate from the landfill is treated
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The concentration of 1,1,2-trichloroethane before and after treatment was
 
1,300 and 1,800 ppb. However the carbon filter was reportedly spent at the
 
time of the survey.
 
1,1,2-Trichloroethane was detected in two samples at 2-3 ppb from
 
Eugene, OR in the National Urban Runoff Program, in which 86 samples of
 
runoff from 19 cities throughout the U.S. were analyzed (Cole et al. 1984).
 
Runoff water from NPL hazardous waste sites containing 1,1,2-trichloroethane
 
might be contaminated with this pollutant. No monitoring studies of runoff
 




No information on the release of 1,1,2-trichloroethane to soil was
 
found in the available literature. It is anticipated that process residues
 
and sludge containing this chemical may be landfilled (Jackson et al. 1984).
 
In an experiment designed to simulate the anaerobic conditions for
 
biodegradation in landfills, 1,1,2-trichloroethane was found to be a
 
biodegradation product of 1,1,2,2-tetrachloroethane (Hallen et al. 1986).
 
Therefore 1,1,2.-trichloroethane may be produced in landfills or other
 






5.3.1 Transport and Partitioning
 
Based on a measured Henry's Law Constant of 9.1x10-4 atm/m3-mol
 
(Ashworth et al. 1988), the volatilization half-life of 1,1,2­
trichloroethane in a model river 1 m deep flowing 1 m/set with a wind of 3
 
m/set is estimated to be 4.5 hr, with resistance in the liquid phase
 
primarily controlling volatilization (Thomas 1982). The half-life in a lake
 
or pond would be much longer. The half-life of 1,1,2-trichloroethane in the
 
lower Rhine river was 1.9 days (Zoeteman et al. 1980). This determination
 
was based on monitoring data and river flow data. This half-life was
 
ascribed to volatilization. In wastewater treatment plants that receive
 
refractory volatile compounds such as 1,1,2-trichloroethane from industrial
 
discharges or other sources, stripping will be an important mechanism for
 
transferring the chemical from the water into the air. In stripping, as
 
opposed to ordinary volatilization, the liquid and gas phases are dispersed
 
with the result that the interfacial surface area is much greater and
 
liquid/gas mass transfer greatly enhanced. In 5 pilot scale treatment
 
plants, 98 - >99% of 1,1,2-trichloroethane was removed by this process (EPA
 
1981). In view of its moderately high vapor pressure and low adsorptivity
 
to soil, 1,1,2-trichloroethane is expected to volatilize rapidly from soil
 
surfaces. In one experiment in which 1,1,2-trichloroethane was applied to a
 
column of sandy soil with a very low organic carbon content, volatilization
 






5. POTENTIAL FOR HUMAN EXPOSURE
 
The adsorption based on organic carbon, Koc, of 1,1,2-trichloroethane
 
on a sandy forest soil (low organic carbon content and cation exchange
 
capacity, CEC), an agricultural soil, and a forest soil (pH lower than the
 
agricultural soil) was 60.0, 63.7, and 108, respectively (Seip et al. 1986).
 
In soil column experiments with these soils, the 1,1,2-trichloroethane moved
 
through the sandy forest soil almost at the same rate as water, whereas the
 
retardation was progressively greater in the agricultural soil and greatest
 
in forest soil; the respective retention coefficients (velocity of water
 
through the soil divided by the velocity of pollutant through the soil)
 
being 1.53, 4.52, and 8.11 (Seip et al. 1986). Therefore 1,1,2­
trichloroethane would not adsorb appreciably to soil, sediment, and
 
suspended solids in the water column and would be expected to readily leach
 
into the subsurface soil and groundwater. A second investigator obtained a
 
Koc of about 70 and a retardation factor of <1.5 using a sandy soil of lower
 




The bioconcentration factors for 1,1,2-trichloroethane reported in the
 
literature are <10 (Kawasaki 1980) and 17 (Isnard and Lambert 1988).
 








In the atmosphere, 1,1,2-trichloroethane will be degraded by reaction
 
with photochemically-produced hydroxyl radicals. The reaction proceeds by
 
H-atom abstraction to yield water and the corresponding C2H2Cl3 radical.
 
The rate of this reaction is 3.28x10-13 cc/molecules-set which would give
 
rise to a half-life of 49 days, assuming an average hydroxyl radical
 




1,1,2-Trichloroethane undergoes both a pH-independent and a basecatalyzed
 
hyrolysis at environmental pH's. The neutral hydrolysis process is a substitution
 
reaction leading to the formation of an alcohol, while the base-catalyzed reaction
 
is an elimination reaction giving rise to l,ldichloroethene and HCl (Mabey et al.
 
1983; Vogel et al. 1987). In the case of 1,1,2-trichloroethane, the base-

catalyzed rate is 5.9x10-3 l/mol-set at 25°C and is dominant above pH 5.4; the 
neutral rate is only 9x10-8 sec-1 
at 80°C (Mabey et al. 1983). The half-life would be 37 years at pH 7 and 135 
days. at pH 9. This is consistent with observations that no significant 
decrease in concentration occurs in 8 days in sterilized water (Jensen and 
Rosenberg 1975). No significant degradation was obtained in seawater, (pH 
7.4-7.7) in 14 days at a temperature of ll-12°C (Jensen and Rosenberg 1975). 
67
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1,1,2-Trichloroethane showed no biodegradation in both a 24-day
 
modified shake flask test and a river die-away test (Mudder and Musterman
 
1982). In two other biodegradabation screening tests, one investigator
 
reported no degradation and the other slow degradation after a long
 
acclimation period (Kawasaki 1980; Tabak et al. 1981). However the unknot
 
extent to which volatilization contributed to losses in the second study
 
makes the results suspect.
 
Under anaerobic conditions, 1,1,2-trichloroethane is reported to
 
undergo dehalogenation. In order to establish whether this is a
 
biologically mediated reaction and not simply an abiotic reaction catalyzed
 
by free iron or iron porphyrin at low redox potential, Dow Chemical
 
conducted 28-day studies in sterile solutions (Klecka and Gonsior 1983).
 
They found that ppm concentrations of 1,1,2-trichloroethane did not undergo
 
nonenzymatic dehalogenation in a sterile, anaerobic solution at pH 7 or when
 




The only study located regarding the degradation of 1,1,2-trichloro­
ethane in soil involved subsurface samples taken from the margin of a
 
floodplain near Lula, Oklahoma (Wilson et al. 1983). These samples were
 
obtained both above the water table of a shallow aquifer and in the
 
unconsolidated material in the saturated zone. A portion of the soil was
 
sterilized and slurries were made and test chemical added. Manipulations
 
made with samples from the saturated zone were carried out under nitrogen.
 
After 16 weeks of incubation, no degradation of 1,1,2-trichloroethan was
 
observed in the samples from above or below the water table. These results
 
are in conflict with other studies (Wilson et al. 1983). It has been
 
suggested that the time frame for the experiment may have been insufficient
 




In an attempt to simulate the anaerobic conditions for biodegradation
 
in landfills, experiments were performed under anoxic conditions using
 
inocula from anaerobic digester units of wastewater treatment facilities
 
that were not acclimated to industrial solvents. After 1 week of incubation
 
with 10 µg/L of 1,1,2-trichloroethane, 0.44 µg/g of vinyl chloride was 
formed, the highest level observed from any of the chlorinated ethanes or 
ethenes studied (Hallen et al. 1986). In further experiments when the 
concentration of inoculum was increased, 4.3 and 5.8 µg/g of vinyl chloride 
was formed after 1 and 2 weeks, respectively. The degradation reactions 
observed not only include reductive dehalogenation but the transformation of 
chlorinated ethanes into ethenes. It is interesting to note that autoclaved 
controls for a 1,1,2-trichloroethane anaerobic biodegradation experiment 
yielded l,l,-dichloroethene (Molton et al. 1987). The formation of 
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Two air samples from rural Oklahoma and air samples from rural areas of
 
the Pacific Northwest did not contain 1,1,2-trichloroethane (Brodzinsky and
 
Singh 1982; Grimsrud and Rasmussen 1975). While both inland and nearshore
 
rural sites near San Francisco averaged 14 parts per trillion (ppt) of
 
1,1,2-trichloroethane, 95% of inland sites and 46% of nearshore sites
 
contained levels above the 6 ppt detection limit (Singh et al. 1977). In
 
930 urban/suburban sites in the U.S. the 25th, 50th, 75th percentile and
 
maximum concentration of 1,1,2-trichloroethane was 0, 9.1, 22, and 11,000
 
ppt, respectively (Brodzinsky and Singh 1982). Other studies that include
 
13 major U.S. cities, report average air concentrations of 1,1,2­
trichloroethane ranging from 6-41 ppt (Singh et al. 1981; Singh et al. 1982;
 
Harkov et al. 1983; Lioy et al. 1983). In the study by Harkov et al.,
 
(1983) air concentrations in Camden, Elizabeth, and Newark, NJ were
 
monitored during the summer of 1981. Of the 111 samples measured, 27%
 
contained a detectable quantity of the pollutant, with a detection limit of
 
5 PPt. The following winter, 41% of the samples from these cities contained
 
1,1,2-trichloroethane. The geometric mean concentrations ranged from 20-50
 
ppt for the winter measurements. This was significantly higher than the 10
 
ppt value obtained the previous summer (Harkov et al. 1987). The median
 
concentration of 1,1,2-trichloroethane in 97 samples obtained from source-

related areas throughout the U.S. was 45 ppt. Of these samples, 25%
 
exceeded 210 ppt and a maximum concentration was 2,300 ppt was measured in
 
Dominguez, CA (Brodzinsky and Singh 1982). The data compiled by Brodzinsky
 
and Singh (1982) has been reviewed and most of it is of good quality. More
 
data have now been added to this National Ambient Volatile Organic Compounds
 
Database bringing the number of monitoring data points to 886 (Shah and
 
Heyerdahl 1988). According to this database, the median concentration of
 
1,1,2-trichloroethane in rural, suburban, and urban areas was 0 ppt; at
 
source-dominated sites the median 1,1,2-trichloroethane concentration was 2
 
PPt. The limited monitoring data suggest that roughly one-quarter to one-

half of the urban population may be exposed to the compound in air. Where
 
1,1,2-trichloroethane is found, most levels range from l0-50 ppt.
 
The only data on levels of 1,1,2-trichloroethane measured in indoor air
 
were contained in a study of eight homes in Knoxville, TN obtained during
 
the winter (Gupta et al. 1984). Eleven of sixteen samples contained 1,1,2­
trichloroethane with a mean [SD] concentration of 14.1 [7.8] µg/m3 (2.5 
[l.4] ppb), however samples taken outside the homes did not contain
 
detectable levels of the chemical. Sources of the 1,1,2-trichloroethane
 
inside the homes may be building materials or solvent-containing products.
 
Traces to 0.32 ppb of 1,1,2-trichloroethane in air samples were found
 
in Iberville Parish, Louisianna, where many organic chemical and producer,
 










1,1,2-Trichloroethane was not detected in composite samples of the
 
water supplies of Philadelphia, PA and Huntington, WV, both of which are
 
derived from surface sources (Dreisch et al. 1980). The levels in finished
 
water from a New Orleans, LA water supply ranged from 0.1 to 8.5 ppb (EPA
 
1980). In a l0-city EPA survey conducted in 1975, 1,1,2-trichloroethane
 
was only detected in the water supply of Miami, FL, which obtains its water
 
from a groundwater source (EPA 1975). The level of contamination was not
 
determined. The maximum concentration of 1,1,2-trichloroethane detected in
 
a survey of community and noncommunity water supplies from groundwater
 
sources and private wells in Suffolk County, NY, was 13 ppb (Zaki et al.
 
1986). 1,1,2-Trichloroethane has been found in 10 private wells in Rhode
 
Island, at a concentration range of 1.0 to 14.0 ppb (RIDH 1989). A survey
 
of Denver, CO, drinking water conducted in late 1985 to early 1986, found no
 
1,1,2-trichloroethane in the samples tested (Rogers et al. 1987). In a U.S.
 
Groundwater Supply survey, none of the 945 groundwater supply sources tested
 
contained 1,1,2-trichloroethane at a quantitation limit of 0.5 ppb (Westrick
 
et al. 1984). 1,1,2-Trichloroethane was found in 6 of the 1174 community
 
wells and 19 of the 617 private wells in a Wisconsin survey conducted in the
 
early 1980s (Krill and Sonzogni 1986). All wells contained less than the
 
recommended health advisory level of 6.1 ppb. Representative samples of
 
ground and surface water were analyzed from the state of New Jersey during
 
1977-1979 (Page 1981). These samples were collected from every county, from
 
urban, suburban, and rural areas, and from areas of every land use common in
 
the state. Seventy-two of the 1069 groundwater samples (6.7%) and 53 of the
 
603 surface water samples (8.7%) contained detectable levels of 1,1,2­
trichloroethane with concentrations as high as 31.1 and 18.7 ppb being found
 
for ground and surface water, respectively. Some of the most polluted wells
 
were under urban land use areas (Page 1981, Greenberg et al. 1982). Ground
 
water near landfill sites in Minnesota and Wisconsin contained up to 31 ppb
 
of 1,1,2-trichloroethane (Sabel and Clark 1984).
 
Of 7 samples from two Ohio River tributaries, 3 were positive for
 
1,1,2-trichloroethane (0.6 ppb maximum). However, only 4% of the samples
 
from the Ohio mainstream were positive and the compound was not found in 88
 
additional stations (Ohio River Valley Sanitation Commission 1980). One
 
measurement of 1,1,2-trichloroethane in marine water was found, 153 ppt off
 
the shore at Point Reyes, CA (Singh et al. 1977).
 
Between 1980 and 1988, 3255 samples of surface water in EPA's STORET
 
database were analyzed for 1,1,2-trichloroethane (STORET 1988). Ten percent
 
of the samples contained the chemical at 10 parts per billion (ppb) or
 
higher. A maximum level of 18,000 ppb was reported in 1982. The maximum
 
concentration of 1,1,2-trichloroethane reported for subsequent years ranged
 
from 10 to 125 ppb. Of the 22,615 samples of groundkater in the database,
 
10% were above 3 ppb. The maximum concentration of 1,1,2-trichloroethane in
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maximum concentration reported ranged from 18 to 1800 ppb. Unfortunately,
 
the detection limit is apparently recorded in STORET when no chemical is
 
detected, so it is impossible to say whether the 90 percentile figure
 




1,1,2-Trichloroethane was found in 25 of the 418 hazardous waste sites
 
listed on the National Priorities List of highest priority sites for
 
possible remedial action (Mitre 1987). Additionally, it was found in 3
 
sites in the Contract Laboratory Statistical Database at mean concentrations
 




1,1,2-Trichloroethane was detected in 9 of 22 commercial batches of
 
technical grade l,l,l-trichloroethane supplied by eight different European
 
manufacturers and dealers (Henschler et al. 1980). The concentration in
 
these samples ranged from 300 to 3,015 ppm and the detection limit was 0.5
 
PPm. It was also found in some commercially available trichloroethylene in
 
Japan (Tsuruta et al. 1983).
 
1,1,2-Trichloroethane was not detected in any of the 46 composite
 
samples of human adipose tissue collected during FY82 as part of the
 
National Human Adipose Tissue Survey (Stanley 1986). The composite
 
specimens represented the nine U.S. census divisions stratified by three age
 
groups (0-14, 15-44, 45 plus). Between July and December 1980, air and
 
breath from nine New Jersey subjects were monitored in a pilot study to
 
measure personal exposure to volatile organic substances for EPA's Total
 
Exposure Assessment Methodology (TEAM) Study (Wallace et al. 1984). The
 
personal air concentrations of 1,1,2-trichloroethane were below the
 
detection limit in 151 of 161 of the samples, 7 contained trace levels of
 
the chemical and the others ranged from 0.14 to 34.70 µg/m3 (0.025 to 6.25 
ppb), with a median of 0.35 µg/m3 (0.063 ppb) (Wallace et al. 1984). 
Breath samples were negative in 44 of 49 samples and the others ranged from 
trace to 5.13 µg/m3 (0.92 ppb), with a median of 0.2 µg/m3 (0,036 ppb). No 
1,1,2-trichloroethane was found in the subjects' drinking water at home.
 
5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE
 
A National Occupational Exposure Survey (NOES) conducted by NIOSH from
 
1981 to 1983 estimates that 1036 workers, including 15 women, are
 
potentially exposed to 1,1,2-trichloroethane in the United States (NIOSH
 
1988). The estimate is provisional, as all of the data for trade name
 
products which may contain 1,1,2-trichloroethane have not been analyzed.
 
The NOES survey was based on field surveys of 4,490 facilities and was
 
designed as a nationwide survey based on a statistical sample of virtually
 
all workplace environments in the United States where eight or more persons
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NIOSH National Occupational Hazard Survey, the highest exposures occurred
 
around blast furnaces, in steel rolling mills and in factories manufacturing
 
technical instruments (Konietzko 1984).
 
Consistent with its tendency to partition into air, most exposures to
 
1,1,2-trichloroethane are from air. Limited monitoring data suggest that
 
one-quarter to one-half of the urban population may be exposed to the
 
compound in air. Where 1,1,2-trichloroethane is found, levels appear to be
 
about l0-50 ppt, for an average daily intake of 1.1-5.5 µg/day. It appears 
that the general population is rarely exposed to 1,1,2-trichloroethane in 
drinking water. 
5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURE
 
If people use products containing 1,1,2-trichloroethane as a solvent,
 
they will be potentially exposed to high levels of this chemical. Moolenaar
 
and Olson (1989), in a written communication as spokesmen for the Dow
 
Chemical Company, however, stated that they are not aware of any consumer
 
uses and that the Dow Chemical Company screens potential customers to
 
determine how they intend to use the 1,1,2-trichloroethane they purchase.
 




While it appears that exposure to high levels of 1,1,2-trichloroethane
 
is rare, there are a few data that indicate that a small number of people
 
may be exposed to high levels of 1,1,2-trichloroethane from contaminated air
 
or drinking water. In Lake Charles, LA, the median and maximum air
 
concentrations of 1,1,2-trichloroethane were 4.8 and 7.4 ppb (Brodzinsky and
 
Singh 1982). This indicates that half of the population of this community
 
have a daily intake of 530 to 820 µg/g, compared with a median intake of 2.6 
µg/g for all the urban/suburban areas of the United States that were 
monitored. Other cities where air concentrations greater than 0.1 ppb were 
sometimes observed were Elizabeth, NJ, Deer Park, TX, Freeport, TX, Geismar, 
LA, Edison, NJ, and Domingues, CA (Brodzinsky and Singh 1982). The data 
indicate that the air concentrations are variable, and only occasionally are 
high levels of 1,1,2-trichloroethane observed. From the available data, it 
is apparent that some wells in Suffolk County, NY, New Jersey, and near 
landfills in Minnesota and Wisconsin contain 1,1,2-trichloroethane 
concentrations as high as 13 to 31 ppb, corresponding to an average daily 
intake of 26 to 62 µg/g per day. The available data are insufficient to 
estimate the number of people that may be exposed to high levels of 1,1,2­
trichloroethane.
 




Physical and Chemical Properties. The physical and chemical properties of
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Environmental Fate. Further investigation would resolve the
 
discrepancies in the data for anaerobic degradation of 1,1,2­
trichloroethane. Additional studies are needed to characterize the nature
 
of the transformation and to clarify whether biotic, abiotic, or catalyzed
 
abiotic reactions are involved. Will these reactions generally occur under
 
environmental conditions? A determination of the half-life in
 
representative groundwater and sediment-water systems would be useful. From
 
the available evidence, biodegradation in aerobic systems appears unlikely,
 




Exposure Levels in Environmental Media. The best estimates of exposure are
 
based on monitoring data and these data add credence to emission and exposure
 
estimates based on production and use. In the case of 1,1,2-trichloroethane,
 
monitoring data are fragmentary and not very recent; most of the data are from the
 
early 1980s or earlier. Information on production and use, particularly that with
 
the largest probability for exposure, is not available. While 1,1,2­
trichloroethane may be contained in some consumer products, the Dow Chemical
 
Company is not aware of any consumer uses (Moolenaar and Olson 1989).
 
Exposure Levels in Humans. Estimates of general population and
 
occupational exposure require current monitoring data or current data on
 
production and use. This information is not available. The use pattern of
 
1,1,2-trichloroethane may have changed since the NOES. If this is the case,
 




Exposure Registries. Other than the NIOSH survey, no exposure
 
registries for 1,1,2-trichloroethane were located. The development of a
 
registry of exposed persons would provide a useful reference tool in
 
assessing exposure levels and frequency. In addition, a registry would
 
allow an assessment of the variations in exposure concentrations by, for
 
example, geography, season, regulatory actions, presence of hazardous waste
 
landfills, or manufacturing or use facility. These assessments, in turn,
 
would provide a better understanding of the needs for some types of research
 
or data acquisition based on the current exposure concentrations.
 
Additionally, such a database of exposures would be useful for linking
 




No information was found which would indicate that there are studies in
 
progress that relate to the environmental fate of 1,1,2-trichloroethane. As
 
part of the Third National Health and Nutrition Evaluation Survey (NHANES
 
III), the Environmental Health Laboratory Sciences Division of the Center
 
for Environmental Health and Injury Control, Centers for Disease Control,
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volatile organic compounds. These data will give an indication of the
 
frequency of occurrence and background levels of these compounds in the
 
general population. NIOSH is continuing to revise its estimates of
 
occupational exposures in its National Occupational Exposure Survey (NOES)
 
through the inclusion of trade name compounds. No other on-going studies
 
regarding general or occupational exposure to 1,1,2-trichloroethane were
 
located. According to the Emergency Planning and Community Right to Know
 
Act of 1986 (EPCRTKA), (§313), (Pub. L. 99-499, Title III, §313), industries
 
are required to submit release information to the EPA. The Toxic Release
 
Inventory (TRI), which contains release information for 1987, became
 
available in May of 1989. This database will be updated yearly and should
 
provide a more reliable estimate of industrial production and emission,
 









The analytical methods for the determination of 1,1,2-trichloroethane
 
in biological matrices are given in Table 6-1. Very few studies exist in
 
the literature that report the analyses of this compound in biological
 
matrices. The discussion about the methods that may be most sensitive for
 
the determination of 1,1,2-trichloroethane levels in environmental samples
 
and the advantages and disadvantages of the commonly used methods as given
 
for environmental samples are thought to be applicable for biological
 
samples because identical quantification methods are used for both kinds of
 
samples. Most biological samples, however, pose unique problems during
 
quantification. For example, the binding of the analytes to protein in
 
samples containing high protein (e.g., whole blood) may result in reduced
 
recovery (Cramer et al. 1988). Both blood and urine are very susceptible to
 
foaming, especially at-high temperatures used during purging (Cramer et al.
 
1988; Michael et al. 1980). Poor and variable recovery has also been
 




The common methods used for the determination of 1,1,2-trichloroethane
 
in environmental samples are given in Table 6-2. The two common methods
 
that are used for the preconcentration of 1,1,2-trichloroethane for the
 
determination of its levels in air are adsorption on a sorbent column or
 
collection in a cryogenically-cooled trap. The disadvantage with the
 
cryogenic cooling is that the method is cumbersome and condensation of
 
moisture in the air may block the passage of further air flow through the
 
trap. The disadvantages with the sorption tubes are that the sorption and
 
desorption efficiencies may not be 100% and that the background impurities
 




The most common method for the determination of 1,1,2-trichloroethane
 
levels in water, sediment, soil, and aquatic species is the purging of the
 
vapor from the sample or its suspension in water with an inert gas and
 
trapping the desorbed vapors in a sorbent trap. Subsequent thermal
 
desorption is used for the quantification of its concentration.
 
The two quantification methods that provide the lowest detection limits
 
are halide-specific detection (e.g., Hall electrolytic conductivity
 
detector) and mass spectrometry. Since the compound has three chlorine
 
atoms, electron capture detection is also very sensitive for this compound.
 
The advantages of halide-specific detectors are that they are not only very
 
sensitive but are also specific for halide compounds. The mass
 
spectrometer, on the other hand, provides an additional confirmation of the
 









when a variety of compounds must be quantified. The inability of halide-

specific detectors to detect and quantify non-halogen compounds can be
 
greatly overcome by using other detectors (e.g., photoionization detector)
 
in series (Lopez-Avila et al, 1987; Driscoll et al. 1987). High-resolution
 
gas chromatography with capillary columns is a better method for volatile
 
compounds than are packed columns because they provide better resolution of
 
closely eluting compounds and increase the sensitivity of detection. In
 
addition, purge and whole-column cryotrapping eliminates the need for the
 
conventional purge-and-trap unit and reduces the time of analysis (Pankow
 
and Rosen 1988). The plugging of the trap by the condensation of moisture
 
during cryotrapping may be avoided by the use of a very wide-bore capillary
 
column, although the chromatographic resolution of such a column is inferior
 
to narrow-bore capillary columns (Pankow and Rosen 1988; Mosesman et al.
 
1987). Regardless of the analytical method used for biological and
 
environmental samples, precautions should be taken during sampling,
 
preservation, and storage of samples to prevent loss from volatilization.
 




Methods for Determining Parent Compounds and Metabolites in Biological
 
Materials. The analytical methods for determining levels of volatile chlorinated
 
compounds in biological media are general ones, applicable to the entire class of
 
chemicals. The publications that describe these methods do not report either the
 
recovery or the detection limit of 1,1,2-trichloroethane in different biological
 
matrices. The study of the levels of the parent compound in human blood, urine or
 
other biological matrices can be useful in deriving a correlation between the
 
level of this compound found in the environment and those found in human tissue or
 
body fluid. Such correlation studies are unavailable for this compound, although
 




No metabolite of 1,1,2-trichloroethane from human exposure to this
 
compound has yet been identified (see Subsection 2.6.3). The changes in
 
metabolite concentrations with time in human blood, urine, or other
 
appropriate biological medium may be useful in estimating its rate of
 
metabolism in humans. In some instances, a metabolite may be useful in
 
correlating the exposed doses to the human body burden. Such studies on the
 
levels of metabolites in human biological matrices are not available for
 
this compound, although metabolic products of this compound from animal and
 
in vitro studies have been identified (see Subsection 2.6.3) and analytical
 
methods for their quantification are available.
 
Methods for Biomarkers of Exposure. No studies were located that
 
identified biomarkers specific for 1,1,2-trichloroethane-induced disease
 
states (see Subsection 2.9.2). If a biomarker for this compound in a human
 






exist between the level of biomarker and a certain health effect, it could
 




Methods for Determining Parent Compounds and Degradation Products in
 
Environmental Media. As shown in Table 6-2, methods are available for the analysis
 
of 1,1,2-trichloroethane in environmental samples. The levels of this compound in
 
different environmental media can be used to indicate whether there could be human
 
exposure to this compound through the inhalation of air and ingestion of drinking
 
water and foods containing 1,1,2-trichloroethane. If a correlation with human
 
tissue or body fluid levels were available, the intake levels from different
 




Although the products of biotic and abiotic processes of this compound in
 
the environment are adequately known, no systematic study is available that
 
measured the concentrations of its reaction products in the environment. In
 
instances where the product(s) of an environmental reaction is more toxic than the
 
parent compound, it is important that the level of the reaction products in the
 
environment be known. It is known that 1,1,2- trichloroethane under anaerobic
 
conditions (e.g. in anaerobic soils leading to contamination to groundwater) may
 
dehydrochlorinate to vinyl chloride (see Section 5.3), a compound more toxic than
 
the parent compound. The analytical methods for the determination of the levels of
 






The Environmental Health Laboratory Sciences Division of the Center for
 
Environmental Health and Injury Control, Centers for Disease Control, is
 
developing methods for the analysis of 1,1,2-trichloroethane and other
 
volatile organic compounds in blood. These methods use purge and trap
 
methodology and magnetic mass spectrometry which gives detection limits in
 




7. REGULATIONS AND ADVISORIES
 
International, national, and state regulations and guidelines pertinent
 
to human exposure to 1,1,2-trichloroethane are summarized in Table 7-1.
 
1,1,2-Trichloroethane is regulated by the Clean Water Effluent
 
Guidelines for the following industrial point sources: electroplating,
 
organic chemicals, steam electric, asbestos, timber products processing,
 
metal finishing, paving and roofing, paint formulating, ink formulating, gum
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Acute Exposure -- Exposure to a chemical for a duration of 14 days or less, as
 
specified in the Toxicological Profiles.
 
Adsorption Coefficient (Koc) -- The ratio of the amount of a chemical
 
adsorbed per unit weight of organic carbon in the soil or sediment to the
 
concentration of the chemical in solution at equilibrium.
 
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or soil
 
(i.e., the solid phase) divided by the amount of chemical in the
 
solution phase, which is in equilibrium with the solid phase, at a fixed
 
solid/solution ratio. It is generally expressed in micrograms of chemical
 
sorbed per gram of soil or sediment.
 
Bioconcentration Factor (BCF) -- The quotient of the concentration of a
 
chemical in aquatic organisms at a specific time or during a discrete time
 
period of exposure divided by the concentration in the surrounding water at
 
the same time or during the same period.
 
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or
 
group of studies, that produces significant increases in the incidence of
 




Carcinogen -- A chemical capable of inducing cancer.
 




Chronic Exposure -- Exposure to a chemical for 365 days or more, as
 
specified in the Toxicological Profiles.
 
Developmental Toxicity -- The occurrence of adverse effects on the
 
developing organism that may result from exposure to a chemical prior to
 
conception (either parent), during prenatal development, or postnatally to
 
the time of sexual maturation. Adverse developmental effects may be
 
detected at any point in the life span of the organism.
 
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a
 
result of prenatal exposure to a chemical; the distinguishing feature
 
between the two terms is the stage of development during which the insult
 
occurred. The terms, as used here, include malformations and variations,
 
altered growth, and in utero death.
 
EPA Health Advisory -- An estimate of acceptable drinking water levels for a
 
chemical substance based on health effects information. A health advisory
 
is not a legally enforceable federal standard, but serves as technical
 






Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental
 
concentration of a contaminant from which one could escape within 30 min without
 
any escape-impairing symptoms or irreversible health effects.
 
Intermediate Exposure -- Exposure to a chemical for a duration of 15-364
 
days as specified in the Toxicological Profiles.
 
Immunologic Toxicity -- The occurrence of adverse effects on the immune
 




In vitro -- Isolated from the living organism and artificially maintained,
 
as in a test tube.
 
In vivo -- Occurring within the living organism.
 
Lethal Concentration(LO) (LCLO) -- The lowest concentration of a chemical in air
 
which has been reported to have caused death in humans or animals.
 
Lethal Concentration(50) (LC50) -- A calculated concentration of a chemical in air
 
to which exposure for a specific length of time is expected to cause death in 50%
 
of a defined experimental animal population.
 
Lethal Dose(LO) (LDLD) -- The lowest dose of a chemical introduced by a
 




Lethal Dose(50) (LD50) -- The dose of a chemical which has been calculated to cause
 
death in 50% of a defined experimental animal population.
 
Lethal Time(50) (LT50) -- A calculated period of time within which a
 
specific concentration of a chemical is expected to cause death in 50% of a
 
defined experimental animal population.
 
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical in a
 
study, or group of studies, that produces statistically or biologically
 
significant increases in frequency or severity of adverse effects between the
 
exposed population and its appropriate control.
 
Malformations -- Permanent structural changes that may adversely affect
 
survival, development, or function.
 
Minimal Risk Level -- An estimate of daily human exposure to a chemical that is
 
likely to be without an appreciable risk of deleterious effects
 






Mutagen -- A substance that causes mutations. A mutation is a change in the
 




Neurotoxicity -- The occurrence of adverse effects on the nervous system
 
following exposure to chemical.
 
No-Observed-Adverse-Effect Level (NOAEL) -- The dose of chemical at which there
 
were no statistically or biologically significant increases in
 
frequency or severity of adverse effects seen between the exposed population
 
and its appropriate control. Effects may be produced at this dose, but they
 
are not considered to be adverse.
 
Octanol-Water Partition Coefficient (Kow) -- The equilibrium ratio of the
 
concentrations of a chemical in n-octanol and water, in dilute solution.
 
Permissible Exposure Limit (PEL) -- An allowable exposure level in workplace air
 
averaged over an 8-hour shift.
 
q1* -- The upper-bound estimate of the low-dose slope of the dose-response
 
curve as determined by the multistage procedure. The ql* can be used to
 
calculate an estimate of carcinogenic potency, the incremental excess cancer
 
risk per unit of exposure (usually µg/L for water, mg/kg/day for food, and 
µg/m3 for air). 
Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps an
 
order of magnitude) of the daily exposure of the human population to a
 
potential hazard that is likely to be without risk of deleterious effects
 
during a lifetime. The RfD is operationally derived from the NOAEL (from
 
animal and human studies) by a consistent application of uncertainty factors
 
that reflect various types of data used to estimate RfDs and an additional
 
modifying factor, which is based on a professional judgment of the entire
 
database on the chemical. The RfDs are not applicable to nonthreshold
 
effects such as cancer.
 
Reportable Quantity (RQ) -- The quantity of a hazardous substance that is
 
considered reportable under CERCLA. Reportable quantities are (1) 1 lb or
 
greater or (2) for selected substances, an amount established by regulation
 
either under CERCLA or under Sect. 311 of the Clean Water Act. Quantities
 
are measured over a 24-hour period.
 
Reproductive Toxicity -- The occurrence of adverse effects on the
 
reproductive system that may result from exposure to a chemical. The
 
toxicity may be directed to the reproductive organs and/or the related
 
endocrine system. The manifestation of such toxicity may be noted as
 
alterations in sexual behavior, fertility, pregnancy outcomes, or
 








Short-Term Exposure Limit (STEL) -- The maximum concentration to which
 
workers can be exposed for up to 15 min continually. No more than four
 
excursions are allowed per day, and there must be at least 60 min between
 
exposure periods. The daily TLV-TWA may not be exceeded.
 
Target Organ Toxicity -- This term covers a broad range of adverse effects
 
on target organs or physiological systems (e.g., renal, cardiovascular)
 
extending from those arising through a single limited exposure to those
 
assumed over a lifetime of exposure to a chemical.
 
Teratogen -- A chemical that causes structural defects that affect the
 
development of an organism.
 
Threshold Limit Value (TLV) -- A concentration of a substance to which most
 
workers can be exposed without adverse effect. The TLV may be expressed as a TWA,
 
as a STEL, or as a CL.
 
Time-weighted Average (TWA) -- An allowable exposure concentration averaged over a
 
normal 8-hour workday or 40-hour workweek.
 
Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route other
 
than inhalation, which is expected to cause a specific toxic effect in 50% of a
 
defined experimental animal population.
 
Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD from
 
experimental data. UFs are intended to account for (1) the variation in
 
sensitivity among the members of the human population, (2) the
 
uncertainty in extrapolating animal data to the case of human, (3) the
 
uncertainty in extrapolating from data obtained in a study that is of less
 
than lifetime exposure, and (4) the uncertainty in using LOAEL data rather
 








A peer review panel was assembled for 1,1,2-trichloroethane. The Panel
 
consisted of the following members: Dr. James V. Bruckner, Associate
 
Professor and Director of Toxicology, University of Georgia College of
 
Pharmacy; Dr. Richard J. Bull, Associate Professor of Pharmacology/
 
Toxicology, University of Washington; Dr. Mildred Christian, Argus Research
 
Laboratories; and Dr. Curtis Klaasen, University of Kansas. These experts
 
collectively have knowledge of 1,1,2-Trichloroethane's physical and chemical
 
properties, toxicokinetics, key health end points, mechanisms of action,
 
human and animal exposure, and quantification of risk to humans. All
 
reviewers were selected in conformity with the conditions for peer review
 




A joint panel of scientists from ATSDR and EPA has reviewed the peer
 
reviewers' comments and determined which comments will be included in the
 
profile. A listing of the peer reviewers' comments not incorporated in the
 
profile, with a brief explanation of the rationale for their exclusion,
 
exists as part of the administrative record for this compound. A list of
 
databases reviewed and a list of unpublished documents cited are also
 
included in the administrative record.
 
The citation of the peer review panel should not be understood to imply
 
their approval of the profile's final content. The responsibility of the
 
content of this profile lies with the Agency for Toxic Substances and
 
Disease Registry.
 
